+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 54958

Chapter 54958 contains a list of PDF Full Texts available from EurekaMag.





Pharmacokinetic evaluation of nabiximols for the treatment of multiple sclerosis pain
, Expert Opinion on Drug Metabolism and Toxicology 9(9): 1219-1228 (2013)

Pharmacokinetic evaluation of oblimersen sodium for the treatment of chronic lymphocytic leukemia
, Expert Opinion on Drug Metabolism and Toxicology 7(6): 765-774 (2011)

Pharmacokinetic evaluation of olanzapine + fluoxetine for the treatment of bipolar depression
, Expert Opinion on Drug Metabolism and Toxicology 9(2): 207-214 (2013)

Pharmacokinetic evaluation of olopatadine for the treatment of allergic rhinitis and conjunctivitis
, Expert Opinion on Drug Metabolism and Toxicology 7(12): 1593-1599 (2011)

Pharmacokinetic evaluation of oral dantrolene in the dog
, Journal of Veterinary Pharmacology and Therapeutics 37(3): 286-294 (2014)

Pharmacokinetic evaluation of palifermin for mucosal protection from chemotherapy and radiation
, Expert Opinion on Drug Metabolism and Toxicology 7(4): 505-515 (2011)

Pharmacokinetic evaluation of pancreatic arterial infusion chemotherapy after unification of the blood supply in an animal model
, Journal of Vascular and Interventional Radiology 21(1): 116-121 (2010)

Pharmacokinetic evaluation of pancreatic arterial infusion chemotherapy with lipid emulsion as a drug carrier in an animal model
, Anti-Cancer Drugs 23(7): 713-717 (2012)

Pharmacokinetic evaluation of pegaptanib octasodium for the treatment of diabetic edema
, Expert Opinion on Drug Metabolism and Toxicology 10(8): 1185-1192 (2014)

Pharmacokinetic evaluation of pemetrexed
, Expert Opinion on Drug Metabolism and Toxicology 7(7): 919-928 (2011)

Pharmacokinetic evaluation of piperacillin-tazobactam
, Expert Opinion on Drug Metabolism and Toxicology 6(8): 1017-1031 (2010)

Pharmacokinetic evaluation of pixantrone for the treatment of non-Hodgkin's lymphoma
, Expert Opinion on Drug Metabolism and Toxicology 7(11): 1441-1448 (2011)

Pharmacokinetic evaluation of platinum derived from cisplatin administered alone and with pemetrexed in head and neck cancer patients
, Cancer ChemoTherapy and Pharmacology 64(2): 233-241 (2009)

Pharmacokinetic evaluation of pomalidomide for the treatment of myeloma
, Expert Opinion on Drug Metabolism and Toxicology 9(11): 1517-1527 (2013)

Pharmacokinetic evaluation of pramipexole
, Expert Opinion on Drug Metabolism and Toxicology 7(10): 1307-1314 (2011)

Pharmacokinetic evaluation of prasugrel for the treatment of myocardial infarction
, Expert Opinion on Drug Metabolism and Toxicology 10(4): 609-620 (2014)

Pharmacokinetic evaluation of rifabutin in combination with lopinavir-ritonavir in patients with HIV infection and active tuberculosis
, Clinical Infectious Diseases 49(9): 1305-1311 (2009)

Pharmacokinetic evaluation of rivaroxaban for the treatment of acute coronary syndromes
, Expert Opinion on Drug Metabolism and Toxicology 8(7): 889-900 (2012 )

Pharmacokinetic evaluation of rofecoxib : comparison of tablet and suspension formulations
, Clinical Drug Investigation 23(8): 503-509 (2003)

Pharmacokinetic evaluation of roflumilast
, Expert Opinion on Drug Metabolism and Toxicology 7(12): 1577-1591 (2011)

Pharmacokinetic evaluation of sildenafil as a pulmonary hypertension treatment
, Expert Opinion on Drug Metabolism and Toxicology 9(9): 1193-1205 (2013)

Pharmacokinetic evaluation of tapentadol extended-release tablets in healthy subjects
, Journal of Opioid Management 9(4): 291-300 (2013)

Pharmacokinetic evaluation of tenofovir disoproxil fumarate released from an intravaginal ring in pigtailed macaques after 6 months of continuous use
, Journal of Medical Primatology 43(5): 364-369 (2014)

Pharmacokinetic evaluation of teriflunomide for the treatment of multiple sclerosis
, Expert Opinion on Drug Metabolism and Toxicology 9(8): 1025-1035 (2013)

Pharmacokinetic evaluation of testosterone-loaded nanocapsules in rats
, International Journal of Biological Macromolecules 72: 28-30 (2015)

Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s Study Team
, HIV Medicine 8(5): 288-294 (2007)

Pharmacokinetic evaluation of the interaction between etravirine and rifabutin or clarithromycin in HIV-negative, healthy volunteers: results from two Phase 1 studies
, Journal of Antimicrobial ChemoTherapy 69(3): 728-734 (2014)

Pharmacokinetic evaluation of the interaction between hepatitis C virus protease inhibitor boceprevir and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors atorvastatin and pravastatin
, Antimicrobial Agents and ChemoTherapy 57(6): 2582-2588 (2013)

Pharmacokinetic evaluation of topical calcineurin inhibitors for treatment of allergic conjunctivitis
, Expert Opinion on Drug Metabolism and Toxicology 10(4): 543-549 (2014)

Pharmacokinetic evaluation of toremifene and its clinical implications for the treatment of osteoporosis
, Expert Opinion on Drug Metabolism and Toxicology 8(4): 505-513 (2012)

Pharmacokinetic evaluation of tramadol and its major metabolites after single oral sustained tablet administration in the dog: a pilot study
, Veterinary Journal 180(2): 253-255 (2009)

Pharmacokinetic evaluation of treprostinil (oral) for the treatment of pulmonary arterial hypertension
, Expert Opinion on Drug Metabolism and Toxicology 10(10): 1445-1453 (2014)

Pharmacokinetic evaluation of ulipristal acetate for uterine leiomyoma treatment
, Expert Opinion on Drug Metabolism and Toxicology 8(7): 901-908 (2012)

Pharmacokinetic evaluation of vadimezan (ASA404, 5,6-dimethylxanthenone-4-acetic acid, DMXAA)
, Expert Opinion on Drug Metabolism and Toxicology 7(10): 1315-1326 (2011)

Pharmacokinetic evaluation of vincristine for the treatment of lymphoid malignancies
, Expert Opinion on Drug Metabolism and Toxicology 10(3): 483-494 (2014)

Pharmacokinetic evaluation of voriconazole treatment in critically ill patients undergoing continuous venovenous hemofiltration
, Therapeutic Drug Monitoring 33(4): 393-397 (2011)

Pharmacokinetic evaluation of vortioxetine for the treatment of major depressive disorder
, Expert Opinion on Drug Metabolism and Toxicology 10(5): 759-766 (2014)

Pharmacokinetic evaluation of zoledronic acid
, Expert Opinion on Drug Metabolism and Toxicology 7(7): 911-918 (2011)

Pharmacokinetic evaluation of zolmitriptan for the treatment of migraines
, Expert Opinion on Drug Metabolism and Toxicology 8(8): 1043-1050 (2012)

Pharmacokinetic evaluations of the co-administrations of vandetanib and metformin, digoxin, midazolam, omeprazole or ranitidine
, Clinical Pharmacokinetics 53(9): 837-847 (2014)

Pharmacokinetic evidence for suboptimal treatment of adrenal insufficiency with currently available hydrocortisone tablets
, Clinical Pharmacokinetics 49(7): 455-463 (2010)

Pharmacokinetic evidence for the long-lasting effect of nor-binaltorphimine, a potent kappa opioid receptor antagonist, in mice
, Neuroscience Letters 552: 98-102 (2013)

Pharmacokinetic evidence on the contribution of intestinal bacterial conversion to beneficial effects of astragaloside IV, a marker compound of astragali radix, in traditional oral use of the herb
, Drug Metabolism and Pharmacokinetics 27(6): 586-597 (2012)

Pharmacokinetic exposure and virological efficacy of a reduced atazanavir dose
, Le Infezioni in Medicina 20(4): 293-295 (2012)

Pharmacokinetic features of difluprednate ophthalmic emulsion in rabbits as determined by glucocorticoid receptor-binding bioassay
, Journal of Ocular Pharmacology and Therapeutics 27(1): 29-34 (2011)

Pharmacokinetic features of the antiparasitic macrocyclic lactones
, Current Pharmaceutical Biotechnology 13(6): 888-911 (2012)

Pharmacokinetic genes do not influence response or tolerance to citalopram in the STAR*D sample
, Plos one 3(4): E1872 (2008)

Pharmacokinetic immunoassay methods in the presence of soluble target
, Journal of Immunological Methods 361(1-2): 75-81 (2010)

Pharmacokinetic individualization of high-dose methotrexate chemotherapy for the treatment of localized osteosarcoma
, Journal of ChemoTherapy 22(3): 186-190 (2010)

Pharmacokinetic interaction between JBP485 and cephalexin in rats
, Drug Metabolism and Disposition: the Biological Fate of Chemicals 38(6): 930-938 (2010)

Pharmacokinetic interaction between TMC114/r and efavirenz in healthy volunteers
, Antiviral Therapy 12(4): 509-514 (2007)

Pharmacokinetic interaction between boceprevir and etravirine in HIV/HCV seronegative volunteers
, Journal of Acquired Immune Deficiency Syndromes 62(1): 67-73 (2013)

Pharmacokinetic interaction between cefaclor and bromhexine in healthy Chinese volunteers
, Zhong Nan Da Xue Xue Bao. Yi Xue Ban 32(5): 855-861 (2007)

Pharmacokinetic interaction between domperidone and ketoconazole leads to QT prolongation in healthy volunteers: a randomized, placebo-controlled, double-blind, crossover study
, British Journal of Clinical Pharmacology 73(3): 411-421 (2012)

Pharmacokinetic interaction between efavirenz and carbamazepine after multiple-dose administration in healthy subjects
, Journal of Clinical Pharmacology 48(8): 948-956 (2008)

Pharmacokinetic interaction between efavirenz and rifampicin in healthy volunteers
, International Journal of Clinical Pharmacology and Therapeutics 49(2): 162-168 (2011)

Pharmacokinetic interaction between ethinyl estradiol, norethindrone and darunavir with low-dose ritonavir in healthy women
, Antiviral Therapy 13(4): 563-569 (2008)

Pharmacokinetic interaction between etravirine or darunavir/ritonavir and artemether/lumefantrine in healthy volunteers: a two-panel, two-way, two-period, randomized trial
, HIV Medicine 14(7): 421-429 (2013)

Pharmacokinetic interaction between febuxostat and morin in rats
, Expert Opinion on Drug Metabolism and Toxicology 10(3): 307-312 (2014)

Pharmacokinetic interaction between fluoxetine and omeprazole in healthy male volunteers: a prospective pilot study
, Current Therapeutic Research Clinical and Experimental 71(6): 360-368 (2010)

Pharmacokinetic interaction between indinavir and darunavir with low-dose ritonavir in healthy volunteers
, Intervirology 53(3): 176-182 (2010)

Pharmacokinetic interaction between itraconazole and metformin in rats: competitive inhibition of metabolism of each drug by each other via hepatic and intestinal CYP3A1/2
, British Journal of Pharmacology 161(4): 815-829 (2010)

Pharmacokinetic interaction between ivabradine and carbamazepine in healthy volunteers
, Journal of Clinical Pharmacy and Therapeutics 36(2): 225-229 (2011)

Pharmacokinetic interaction between ivabradine and phenytoin in healthy subjects
, Clinical Drug Investigation 32(8): 533-538 (2012)

Pharmacokinetic interaction between liquiritigenin (LQ) and DDB: increased glucuronidation of LQ in the liver possibly due to increased hepatic blood flow rate by DDB
, European Journal of Pharmaceutical Sciences 39(1-3): 181-189 (2010)

Pharmacokinetic interaction between losartan and Rhodiola rosea in rabbits
, Pharmacology 91(1-2): 112-116 (2013)

Pharmacokinetic interaction between maraviroc and etravirine in HIV-infected patients receiving regimens containing both drugs and no ritonavir-boosted protease inhibitor
, Journal of Antimicrobial ChemoTherapy 67(11): 2779-2781 (2012)

Pharmacokinetic interaction between maraviroc and fosamprenavir-ritonavir: an open-label, fixed-sequence study in healthy subjects
, Antimicrobial Agents and ChemoTherapy 57(12): 6158-6164 (2013)

Pharmacokinetic interaction between metoprolol and SP-8203 in rats: competitive inhibition for the metabolism of metoprolol by SP-8203 via hepatic CYP2D subfamily
, Xenobiotica; the Fate of Foreign Compounds in Biological Systems 42(10): 1017-1027 (2012)

Pharmacokinetic interaction between nevirapine and darunavir with low-dose ritonavir in HIV-1-infected patients
, British Journal of Clinical Pharmacology 68(1): 116-119 (2009)

Pharmacokinetic interaction between nevirapine and nortriptyline in rats: inhibition of nevirapine metabolism by nortriptyline
, Antimicrobial Agents and ChemoTherapy 58(12): 7041-7048 (2014)

Pharmacokinetic interaction between oltipraz and silymarin in rats
, Journal of Pharmacy and Pharmaceutical Sciences 12(1): 1-16 (2009)

Pharmacokinetic interaction between oral lovastatin and verapamil in healthy subjects: role of P-glycoprotein inhibition by lovastatin
, European Journal of Clinical Pharmacology 66(3): 285-290 (2010)

Pharmacokinetic interaction between pitavastatin and valsartan: a randomized, open-labeled crossover study in healthy male Korean volunteers
, Clinical Therapeutics 34(4): 958-965 (2012)

Pharmacokinetic interaction between prasugrel and ritonavir in healthy volunteers
, Basic and Clinical Pharmacology and Toxicology 112(2): 132-137 (2013)

Pharmacokinetic interaction between pravastatin and olmesartan in relation to SLCO1B1 polymorphism
, Journal of Human Genetics 53(10): 899-904 (2008)

Pharmacokinetic interaction between puerarin and edaravone, and effect of borneol on the brain distribution kinetics of puerarin in rats
, Journal of Pharmacy and Pharmacology 62(3): 360-367 (2010)

Pharmacokinetic interaction between pyronaridine-artesunate and metoprolol
, Antimicrobial Agents and ChemoTherapy 58(10): 5900-5908 (2014)

Pharmacokinetic interaction between rosuvastatin and metformin in healthy Korean male volunteers: a randomized, open-label, 3-period, crossover, multiple-dose study
, Clinical Therapeutics 36(8): 1171-1181 (2014)

Pharmacokinetic interaction between rosuvastatin and olmesartan: a randomized, open-label, 3-period, multiple-dose crossover study in healthy Korean male subjects
, Clinical Therapeutics 36(8): 1159-1170 (2014)

Pharmacokinetic interaction between rosuvastatin and telmisartan in healthy Korean male volunteers: a randomized, open-label, two-period, crossover, multiple-dose study
, Clinical Therapeutics 36(8): 1147-1158 (2014)

Pharmacokinetic interaction between scutellarin and valsartan in rats
, Yao Xue Xue Bao 48(4): 541-546 (2013)

Pharmacokinetic interaction between simvastatin and fenofibrate with staggered and simultaneous dosing: Does it matter?
, Journal of Clinical Pharmacology 54(9): 1038-1047 (2014)

Pharmacokinetic interaction between sodium valproate and mycophenolate in renal allograft recipients
, Transplantation 88(9): 1143-1145 (2009)

Pharmacokinetic interaction between tacrolimus and amlodipine in a renal transplant child
, Transplantation 93(7): E29 (2012)

Pharmacokinetic interaction between tacrolimus and berberine in a child with idiopathic nephrotic syndrome
, European Journal of Clinical Pharmacology 69(10): 1861-1862 (2013)

Pharmacokinetic interaction between tamoxifen and ondansetron in rats: non-competitive (hepatic) and competitive (intestinal) inhibition of tamoxifen metabolism by ondansetron via CYP2D subfamily and 3A1/2
, Cancer ChemoTherapy and Pharmacology 65(3): 407-418 (2010)

Pharmacokinetic interaction between telithromycin and metformin in diabetes mellitus rats
, Xenobiotica; the Fate of Foreign Compounds in Biological Systems 40(3): 217-224 (2010)

Pharmacokinetic interaction between the flavonoid luteolin and gamma-hydroxybutyrate in rats: potential involvement of monocarboxylate transporters
, Aaps Journal 10(1): 47-55 (2008)

Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers
, Hepatology 56(5): 1622-1630 (2012)

Pharmacokinetic interaction between verapamil and methylxanthine derivatives in mice
, Drug Metabolism Letters 4(1): 15-24 (2010)

Pharmacokinetic interaction between zidovudine and trimethoprim/sulphamethoxazole in HIV-1 infected children
, Canadian Journal of Infectious Diseases 11(5): 254-258 (2000)

Pharmacokinetic interaction between zolpidem and carbamazepine in healthy volunteers
, Journal of Clinical Pharmacology 51(8): 1233-1236 (2011)

Pharmacokinetic interaction between zolpidem and ciprofloxacin in healthy volunteers
, European Journal of Drug Metabolism and Pharmacokinetics 35(3-4): 83-87 (2011)

Pharmacokinetic interaction between ϵ-acetamidocaproic acid (AACA) and cimetidine in indomethacin-induced acute gastric ulcer and control rats: inhibition of active renal secretion of AACA by cimetidine
, Xenobiotica; the Fate of Foreign Compounds in Biological Systems 41(5): 409-415 (2011)

Pharmacokinetic interaction involving fenofibrate and everolimus
, Annals of Oncology 26(1): 248-249 (2015)

Pharmacokinetic interaction involving sorafenib and the calcium-channel blocker felodipine in a patient with hepatocellular carcinoma
, Investigational new Drugs 29(6): 1511-1514 (2011)

Pharmacokinetic interaction of ciprofloxacin with diclofenac: a single-dose, two-period crossover study in healthy adult volunteers
, Clinical Drug Investigation 29(4): 275-281 (2009)

Pharmacokinetic interaction of entinostat and lapatinib following single and co-oral administration in rats
, Xenobiotica; the Fate of Foreign Compounds in Biological Systems 44(11): 1009-1013 (2014)

Pharmacokinetic interaction of fimasartan, a new angiotensin II receptor antagonist, with amlodipine in healthy volunteers
, Journal of Cardiovascular Pharmacology 57(6): 682-689 (2011)

Pharmacokinetic interaction of flecainide and paroxetine in relation to the CYP2D6*10 allele in healthy Korean subjects
, British Journal of Clinical Pharmacology 66(5): 660-666 (2008)

Pharmacokinetic interaction of garlic and atorvastatin in dyslipidemic rats
, Indian Journal of Pharmacology 44(2): 246-252 (2012)

Pharmacokinetic interaction of intramammary ceftriaxone and oral polyherbal drug (Fibrosin(®)) in goats
, Drug Metabolism and Drug Interactions 26(4): 191-196 (2011)

Pharmacokinetic interaction of maraviroc with tacrolimus in a patient coinfected with HIV and hepatitis B virus following hepatic transplant due to hepatocellular carcinoma
, Journal of Antimicrobial ChemoTherapy 68(4): 972-974 (2013)

Pharmacokinetic interaction of pioglitazone hydrochloride and atorvastatin calcium in Beagle dogs
, Yao Xue Xue Bao 48(5): 741-745 (2013)

Pharmacokinetic interaction of rifapentine and raltegravir in healthy volunteers
, Journal of Antimicrobial ChemoTherapy 69(4): 1079-1085 (2014)

Pharmacokinetic interaction of ritonavir-boosted elvitegravir and maraviroc
, Journal of Acquired Immune Deficiency Syndromes 53(2): 209-214 (2010)

Pharmacokinetic interaction of single dose of piperine with steady-state carbamazepine in epilepsy patients
, PhytoTherapy Research 23(9): 1281-1286 (2009)

Pharmacokinetic interaction of some antitubercular drugs with caraway: implications in the enhancement of drug bioavailability
, Human and Experimental Toxicology 28(4): 175-184 (2009)

Pharmacokinetic interaction of telmisartan with s-amlodipine: an open-label, two-period crossover study in healthy Korean male volunteers
, Clinical Therapeutics 34(7): 1625-1635 (2012)

Pharmacokinetic interaction of the direct renin inhibitor aliskiren with furosemide and extended-release isosorbide-5-mononitrate in healthy subjects
, Cardiovascular Therapeutics 26(4): 238-246 (2008)

Pharmacokinetic interaction of vicriviroc with other antiretroviral agents: results from a series of fixed-sequence and parallel-group clinical trials
, Clinical Pharmacokinetics 50(4): 267-280 (2011)

Pharmacokinetic interaction profile of riociguat, a new soluble guanylate cyclase stimulator, in vitro
, Pulmonary Pharmacology and Therapeutics 28(2): 130-137 (2014)

Pharmacokinetic interaction studies of co-administration of ticagrelor and atorvastatin or simvastatin in healthy volunteers
, European Journal of Clinical Pharmacology 69(3): 477-487 (2013)

Pharmacokinetic interaction studies of fenugreek with CYP3A substrates cyclosporine and carbamazepine
, European Journal of Drug Metabolism and Pharmacokinetics 39(2): 147-153 (2014)

Pharmacokinetic interaction studies of tanshinones with tolbutamide, a model CYP2C11 probe substrate, using liver microsomes, primary hepatocytes and in vivo in the rat
, Phytomedicine 17(3-4): 203-211 (2010)

Pharmacokinetic interaction study between eslicarbazepine acetate and lamotrigine in healthy subjects
, Acta Neurologica Scandinavica 121(4): 257-264 (2010)

Pharmacokinetic interaction study between eslicarbazepine acetate and topiramate in healthy subjects
, Current Medical Research and Opinion 26(6): 1355-1362 (2010)

Pharmacokinetic interaction study between quercetin and valsartan in rats and in vitro models
, Drug Development and Industrial Pharmacy 39(6): 865-872 (2013)

Pharmacokinetic interaction study of ritonavir-boosted saquinavir in combination with rifabutin in healthy subjects
, Antimicrobial Agents and ChemoTherapy 55(2): 680-687 (2011)

Pharmacokinetic interaction study of ticagrelor and cyclosporine in healthy volunteers
, Clinical Drug Investigation 34(8): 529-536 (2014)

Pharmacokinetic interaction study with fixed high dose combinations of candesartan cilexetil and hydrochlorothiazide
, International Journal of Clinical Pharmacology and Therapeutics 49(12): 750-755 (2011)

Pharmacokinetic interactions
, Enfermedades Infecciosas y Microbiologia Clinica 31(Suppl. 2): 12-19 (2013)

Pharmacokinetic interactions between alitretinoin and ketoconazole or simvastatin or ciclosporin A
, Clinical and Experimental Dermatology 36(Suppl. 2): 24-28 (2011)

Pharmacokinetic interactions between antiretroviral drugs and herbal medicines
, British Journal of Hospital Medicine 73(3): 132-136 (2012)

Pharmacokinetic interactions between buprenorphine/naloxone and once-daily lopinavir/ritonavir
, Journal of Acquired Immune Deficiency Syndromes 54(5): 511-514 (2010)

Pharmacokinetic interactions between buprenorphine/naloxone and raltegravir in subjects receiving chronic buprenorphine/naloxone treatment
, American Journal of Drug and Alcohol Abuse 39(2): 80-85 (2013)

Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
, Drug and Alcohol Dependence 105(3): 234-239 (2009)

Pharmacokinetic interactions between ciprofloxacin and itraconazole in healthy male volunteers
, Biopharmaceutics and Drug Disposition 32(3): 168-174 (2011)

Pharmacokinetic interactions between clopidogrel and rosuvastatin: effects on vascular protection in subjects with coronary heart disease
, International Journal of Cardiology 158(1): 125-129 (2012)

Pharmacokinetic interactions between contraceptives and antiepileptic drugs
, Seizure 17(2): 141-144 (2008)

Pharmacokinetic interactions between darunavir/ritonavir and opioid maintenance therapy using methadone or buprenorphine/naloxone
, Journal of Clinical Pharmacology 51(2): 271-278 (2011)

Pharmacokinetic interactions between depot medroxyprogesterone acetate and combination antiretroviral therapy
, Fertility and Sterility 90(4): 965-971 (2008)

Pharmacokinetic interactions between eperisone hydrochloride and aceclofenac: a randomized, open-label, crossover study of healthy Korean men
, Clinical Therapeutics 35(10): 1528-1535 (2013)

Pharmacokinetic interactions between ethanol and heroin: a study on post-mortem cases
, Forensic Science International 242: 127-134 (2014)

Pharmacokinetic interactions between etravirine and non-antiretroviral drugs
, Clinical Pharmacokinetics 50(1): 25-39 (2011)

Pharmacokinetic interactions between lersivirine and zidovudine, tenofovir disoproxil fumarate/emtricitabine and abacavir/lamivudine
, Antiviral Therapy 18(6): 745-754 (2013)

Pharmacokinetic interactions between monoamine oxidase A inhibitor harmaline and 5-methoxy-N,N-dimethyltryptamine, and the impact of CYP2D6 status
, Drug Metabolism and Disposition: the Biological Fate of Chemicals 41(5): 975-986 (2013)

Pharmacokinetic interactions between primaquine and chloroquine
, Antimicrobial Agents and ChemoTherapy 58(6): 3354-3359 (2014)

Pharmacokinetic interactions between primaquine and pyronaridine-artesunate in healthy adult Thai subjects
, Antimicrobial Agents and ChemoTherapy 59(1): 505-513 (2015)

Pharmacokinetic interactions between rebamipide and selected nonsteroidal anti-inflammatory drugs in rats
, European Journal of Pharmaceutical Sciences 53: 28-34 (2014)

Pharmacokinetic interactions between rifabutin and lopinavir/ritonavir in HIV-infected patients with mycobacterial co-infection
, Journal of Antimicrobial ChemoTherapy 64(4): 871-873 (2009)

Pharmacokinetic interactions between ritonavir-boosted darunavir and NNRTIs: a report of 3 cases
, Aids Reader 18(9): 466 (2008)

Pharmacokinetic interactions between simvastatin and setipiprant, a CRTH2 antagonist
, European Journal of Clinical Pharmacology 71(1): 15-23 (2015)

Pharmacokinetic interactions between the hepatitis C virus protease inhibitor boceprevir and ritonavir-boosted HIV-1 protease inhibitors atazanavir, darunavir, and lopinavir
, Clinical Infectious Diseases 56(5): 718-726 (2013)

Pharmacokinetic interactions between the hormonal emergency contraception, levonorgestrel (Plan B), and Efavirenz
, Infectious Diseases in Obstetrics and Gynecology 2012: 137192 (2012)

Pharmacokinetic interactions between the orexin receptor antagonist almorexant and the CYP3A4 inhibitors ketoconazole and diltiazem
, Journal of Pharmaceutical Sciences 103(5): 1548-1556 (2014)

Pharmacokinetic interactions between topiramate and pioglitazone and metformin
, Epilepsy Research 108(9): 1519-1532 (2014)

Pharmacokinetic interactions of clopidogrel with quercetin, telmisartan, and cyclosporine A in rats and dogs
, Archives of Pharmacal Research 35(10): 1831-1837 (2012)

Pharmacokinetic interactions of dasatinib and docetaxel
, Lancet. Oncology 15(2): E51 (2014)

Pharmacokinetic interactions of flunixin meglumine and doxycycline in broiler chickens
, Journal of Veterinary Pharmacology and Therapeutics 36(1): 85-88 (2013)

Pharmacokinetic interactions of maraviroc with darunavir-ritonavir, etravirine, and etravirine-darunavir-ritonavir in healthy volunteers: results of two drug interaction trials
, Antimicrobial Agents and ChemoTherapy 55(5): 2290-2296 (2011)

Pharmacokinetic interactions of marbofloxacin with anti-inflammatory drugs in buffalo calves
, Veterinary Record 169(7): 182 (2011)

Pharmacokinetic interactions of selective serotonin reuptake inhibitors with other commonly prescribed drugs in the era of pharmacogenomics
, Drug Metabolism and Drug Interactions 27(1): 19-31 (2012)

Pharmacokinetic interactions of telaprevir with other drugs
, Enfermedades Infecciosas y Microbiologia Clinica 31(Suppl. 3): 37-48 (2013)

Pharmacokinetic interactions of the microsomal triglyceride transfer protein inhibitor, lomitapide, with drugs commonly used in the management of hypercholesterolemia
, PharmacoTherapy 34(3): 227-239 (2014)

Pharmacokinetic interactions of valsartan and hydrochlorothiazide: an open-label, randomized, 4-period crossover study in healthy Egyptian male volunteers
, Clinical Therapeutics 35(6): 846-861 (2013)

Pharmacokinetic interactions with antiepileptic drugs: always the bad actor or simply misunderstood?
, Epilepsy Currents 10(5): 113-115 (2010)

Pharmacokinetic interplay of phase II metabolism and transport: a theoretical study
, Journal of Pharmaceutical Sciences 101(1): 381-393 (2012)

Pharmacokinetic investigation of imatinib using accelerator mass spectrometry in patients with chronic myeloid leukemia
, Clinical Cancer Research 13(14): 4164-4169 (2007)

Pharmacokinetic investigation of increased efficacy against malignant gliomas of carboplatin combined with hyperbaric oxygenation
, NeurologiaMedico-Chirurgica49(5):193 (2009)

Pharmacokinetic investigation on a novel antitumour platinum compound in rabbit plasma by inductively coupled plasma mass spectrometry after intravenous administration
, Drug Development and Industrial Pharmacy 34(5): 472-477 (2008)

Pharmacokinetic issues for antibiotics in the critically ill patient
, Critical Care Medicine 37(3): 840 (2009)

Pharmacokinetic issues of imaging with nanoparticles: focusing on carbon nanotubes and quantum dots
, Molecular Imaging and Biology 15(5): 507-520 (2013)

Pharmacokinetic mapping for lesion classification in dynamic breast MRI
, Journal of Magnetic Resonance Imaging 31(6): 1371-1378 (2010)

Pharmacokinetic mechanism involved in the prolonged high retention of laninamivir in mouse respiratory tissues after intranasal administration of its prodrug laninamivir octanoate
, Drug Metabolism and Disposition: the Biological Fate of Chemicals 41(1): 180-187 (2013)

Pharmacokinetic mechanism of enhancement by Radix Pueraria flavonoids on the hyperglycemic effects of Cortex Mori extract in rats
, Journal of Ethnopharmacology 151(2): 846-851 (2014)

Pharmacokinetic mismatch of tuberculosis drugs
, Antimicrobial Agents and ChemoTherapy 56(3): 1666; Author Reply 1667 (2012)

Pharmacokinetic model incorporating mechanism-based inactivation of CYP2D6 can explain both non-linear kinetics and drug interactions of paroxetine
, International Journal of Clinical Pharmacology and Therapeutics 51(5): 374-382 (2013)

Pharmacokinetic model-driven remifentanil administration in the morbidly obese: the 'critical weight' and the 'fictitious height', a possible solution to an unsolved problem?
, Clinical Pharmacokinetics 48(6): 397-398 (2009)

Pharmacokinetic modeling and Monte Carlo simulation of ondansetron following oral administration in dogs
, Journal of Veterinary Pharmacology and Therapeutics 38(2): 199-202 (2015)

Pharmacokinetic modeling and [¹²³]5-IA-85380 single photon emission computed tomography imaging in baboons: optimization of dosing regimen for ABT-089
, Journal of Pharmacology and Experimental Therapeutics 336(3): 716-723 (2011)

Pharmacokinetic modeling and development of Bayesian estimators in kidney transplant patients receiving the tacrolimus once-daily formulation
, Therapeutic Drug Monitoring 32(2): 129-135 (2010)

Pharmacokinetic modeling and prediction of plasma pyrrole-imidazole polyamide concentration in rats using simultaneous urinary and biliary excretion data
, Biological and Pharmaceutical Bulletin 32(5): 921-927 (2009)

Pharmacokinetic modeling and simulation of biweekly subcutaneous immunoglobulin dosing in primary immunodeficiency
, Postgraduate Medicine 125(6): 53-61 (2013)

Pharmacokinetic modeling and simulation of gastrointestinal transit effects on plasma concentrations of drugs from mixed immediate-release and enteric-coated pellet formulations
, Pharmaceutical Development and Technology 12(2): 193-202 (2007)

Pharmacokinetic modeling and simulation of procainamide and N-acetylprocainamide in a patient receiving continuous renal replacement therapy: a novel approach to guide renal dose adjustments
, American Journal of Kidney Diseases 61(6): 1046-1048 (2013)

Pharmacokinetic modeling of P-glycoprotein function at the rat and human blood-brain barriers studied with (R)-[11C]verapamil positron emission tomography
, Ejnmmi Research 2(1): 58 (2012)

Pharmacokinetic modeling of an induction regimen for in vivo combined testing of novel drugs against pediatric acute lymphoblastic leukemia xenografts
, Plos one 7(3): E33894 (2012)

Pharmacokinetic modeling of ascorbate diffusion through normal and tumor tissue
, Free Radical Biology and Medicine 77: 340-352 (2014)

Pharmacokinetic modeling of carbamazepine based on clinical data from Serbian epileptic patients
, Methods and Findings in Experimental and Clinical Pharmacology 30(9): 707-713 (2008)

Pharmacokinetic modeling of delayed gadolinium enhancement in the myocardium
, Magnetic Resonance in Medicine 60(6): 1524-1530 (2008)

Pharmacokinetic modeling of doxorubicin pharmacokinetics in dogs deficient in ABCB1 drug transporters
, Journal of Veterinary Internal Medicine 24(3): 579-586 (2010)

Pharmacokinetic modeling of glimepiride plasma concentration in healthy subjects
, Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 115(3): 949-953 (2011)

Pharmacokinetic modeling of motexafin gadolinium disposition in mouse tissues using optical pharmacokinetic system measurements
, Photodiagnosis and Photodynamic Therapy 5(4): 276-284 (2008)

Pharmacokinetic modeling of plasma and intracellular concentrations of raltegravir in healthy volunteers
, Antimicrobial Agents and ChemoTherapy 55(9): 4090-4095 (2011)

Pharmacokinetic modeling of subcutaneous heroin and its metabolites in blood and brain of mice
, Addiction Biology 18(1): 1-7 (2013)

Pharmacokinetic modeling of the dosing interval dependency for the interaction between itraconazole and triazolam
, International Journal of Clinical Pharmacology and Therapeutics 48(6): 356-366 (2010)

Pharmacokinetic modeling of the hepatobiliary transport mediated by cooperation of uptake and efflux transporters
, Drug Metabolism Reviews 42(3): 539-550 (2010)

Pharmacokinetic modeling of the high-dose bolus regimen of tirofiban in patients with severe renal impairment
, Coronary Artery Disease 23(3): 208-214 (2012)

Pharmacokinetic modeling of the subcutaneous absorption of therapeutic proteins
, Drug Metabolism and Disposition: the Biological Fate of Chemicals 42(11): 1890-1905 (2014)

Pharmacokinetic modeling of tumor bioluminescence implicates efflux, and not influx, as the bigger hurdle in cancer drug therapy
, Cancer Research 71(3): 686-692 (2011)

Pharmacokinetic modeling of valproate from clinical data in Serbian epileptic patients
, Methods and Findings in Experimental and Clinical Pharmacology 29(10): 673-679 (2007)

Pharmacokinetic modeling optimizes inhibition of the 'undruggable' EWS-FLI1 transcription factor in Ewing Sarcoma
, Oncotarget 5(2): 338-350 (2014)

Pharmacokinetic modeling: prediction and evaluation of route dependent dosimetry of bisphenol A in monkeys with extrapolation to humans
, Toxicology and Applied Pharmacology 257(1): 122-136 (2011)

Pharmacokinetic modelling and development of Bayesian estimators for therapeutic drug monitoring of mycophenolate mofetil in reduced-intensity haematopoietic stem cell transplantation
, Clinical Pharmacokinetics 48(10): 667-675 (2009)

Pharmacokinetic modelling of N-(4-[(18)F]fluorobenzoyl)interleukin-2 binding to activated lymphocytes in an xenograft model of inflammation
, European Journal of Nuclear Medicine and Molecular Imaging 39(10): 1551-1560 (2012)

Pharmacokinetic modelling of microencapsulated metronidazole
, Yao Xue Xue Bao 44(6): 674-679 (2009)

Pharmacokinetic modelling of serum and bronchial concentrations for clarithromycin and telithromycin, and site-specific pharmacodynamic simulation for their dosages
, Journal of Clinical Pharmacy and Therapeutics 39(4): 411-417 (2014)

Pharmacokinetic modelling of the anti-malarial drug artesunate and its active metabolite dihydroartemisinin
, Computer Methods and Programs in Biomedicine 112(1): 1-15 (2013)

Pharmacokinetic modelling of the plasma protein binding of mycophenolic acid in renal transplant recipients
, Clinical Pharmacokinetics 48(7): 463-476 (2009)

Pharmacokinetic modelling of valproate in epileptic patients
, Medicinski Pregled 63(5-6): 349-355 (2010)

Pharmacokinetic models for FcRn-mediated IgG disposition
, Journal of Biomedicine and Biotechnology 2012: 282989 (2012)

Pharmacokinetic models for propofol: defining and illuminating the devil in the detail
, British Journal of Anaesthesia 104(2): 261 (2010)

Pharmacokinetic models of propofol for TCI
, Anaesthesia 63(2): 206; Author Reply 206-7 (2008)

Pharmacokinetic modulation of radiolabeled chelates facilitated by phosphonate ester coordinating groups
, Molecular Pharmaceutics 9(8): 2180-2186 (2012)

Pharmacokinetic monitoring as a new tool to individualize anti-TNF therapy
, Farmacia Hospitalaria 38(2): 83-85 (2014)

Pharmacokinetic monitoring is still required for intravenous busulfan in SCT for small children
, International Journal of Hematology 91(4): 728-730 (2010)

Pharmacokinetic monitoring of 5-fluorouracil may improve the clinical benefit with an individualized regimen-a case report
, Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(1): 131-134 (2009)

Pharmacokinetic monitoring of HIV-1 protease inhibitors in the antiretroviral therapy
, Acta Poloniae Pharmaceutica 65(1): 93-100 (2008)

Pharmacokinetic monitoring of antiepileptic drugs
, Farmacia Hospitalaria 35(6): 326-339 (2011)

Pharmacokinetic monitoring of intravenous cyclosporine A in pediatric stem-cell transplant recipients. The trough level is not enough
, Pediatric Transplantation 13(4): 444-450 (2009)

Pharmacokinetic monitoring of mycophenolic acid in heart transplant patients: correlation the side-effects and rejections with pharmacokinetic parameters
, Annals of Transplantation 17(1): 68-78 (2012)

Pharmacokinetic of ALA and h-ALA induced porphyrins in the models Mycobacterium phlei and Mycobacterium smegmatis
, Journal of Photochemistry and Photobiology. B Biology 97(1): 1-7 (2009)

Pharmacokinetic of antiepileptic drugs in patients with hepatic or renal impairment
, Clinical Pharmacokinetics 53(1): 29-49 (2014)

Pharmacokinetic of diclofenac in the presence and absence of glibenclamide in the rat
, Journal of Pharmacy and Pharmaceutical Sciences 12(3): 280-287 (2009)

Pharmacokinetic of four alkaloids of Yanshu injection in Beagel dogs
, Zhongguo Zhong Yao Za Zhi 37(12): 1845-1849 (2012)

Pharmacokinetic of four probe drugs in adriamycin-induced nephropathy rat
, European Review for Medical and Pharmacological Sciences 18(10): 1439-1447 (2014)

Pharmacokinetic of gabapentin 600 mg tablet in Thai healthy subjects
, Journal of the Medical Association of Thailand 95(4): 583-589 (2012)

Pharmacokinetic of levamisole in speckled surubim Pseudoplatystoma corruscans
, Journal of Veterinary Pharmacology and Therapeutics 36(3): 298-301 (2013)

Pharmacokinetic of sulfisoxazole in aqueous humor after topical and subconjunctival application in dogs
, Pakistan Journal of Biological Sciences 10(22): 4168-4170 (2007)

Pharmacokinetic optimisation of novel indole-2-carboxamide cannabinoid CB1 antagonists
, Bioorganic and Medicinal Chemistry Letters 21(7): 2034-2039 (2011)

Pharmacokinetic optimization of antiretroviral therapy in children and adolescents
, Clinical Pharmacokinetics 50(3): 143-189 (2011)

Pharmacokinetic optimization of antiretroviral therapy in pregnancy
, Clinical Pharmacokinetics 51(10): 639-659 (2012)

Pharmacokinetic optimization of class-selective histone deacetylase inhibitors and identification of associated candidate predictive biomarkers of hepatocellular carcinoma tumor response
, Journal of Medicinal Chemistry 55(20): 8903-8925 (2012)

Pharmacokinetic optimization of four soluble epoxide hydrolase inhibitors for use in a murine model of inflammation
, British Journal of Pharmacology 156(2): 284-296 (2009)

Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part I
, Clinical Pharmacokinetics 48(7): 419-462 (2009)

Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part II
, Clinical Pharmacokinetics 48(8): 489-516 (2009)

Pharmacokinetic outcomes of a simplified, weight-based, extended-interval gentamicin dosing protocol in critically ill neonates
, PharmacoTherapy 29(11): 1297-1305 (2009)

Pharmacokinetic overview of ethinyl estradiol dose and bioavailability using two transdermal contraceptive systems and a standard combined oral contraceptive
, International Journal of Clinical Pharmacology and Therapeutics 52(12): 1059-1070 (2014)

Pharmacokinetic parameter and residua of 63Ni-NiCl2 in rat
, Yao Xue Xue Bao 43(2): 224-226 (2008)

Pharmacokinetic parameters and a theoretical study about metabolism of BR-AEA (a salbutamol derivative) in rabbit
, Journal of Enzyme Inhibition and Medicinal Chemistry 25(3): 340-346 (2010)

Pharmacokinetic parameters and tissue distribution of magnetic Fe(3)O(4) nanoparticles in mice
, International Journal of Nanomedicine 5: 861-866 (2010)

Pharmacokinetic parameters estimation using adaptive Bayesian P-splines models
, Pharmaceutical Statistics 8(2): 98-112 (2009)

Pharmacokinetic parameters for assessing bioequivalence of epinephrine autoinjectors
, Annals of Allergy Asthma and Immunology 112(3): 269 (2014)

Pharmacokinetic parameters from 3-Tesla DCE-MRI as surrogate biomarkers of antitumor effects of bevacizumab plus FOLFIRI in colorectal cancer with liver metastasis
, International Journal of Cancer 130(10): 2359-2365 (2012)

Pharmacokinetic parameters of amoxicillin in pigs and poultry
, Acta Poloniae Pharmaceutica 67(6): 729-732 (2010)

Pharmacokinetic parameters of artesunate and dihydroartemisinin in rats infected with Fasciola hepatica
, Journal of Antimicrobial ChemoTherapy 63(3): 543-549 (2009)

Pharmacokinetic parameters of morroniside in iridoid glycosides of Fructus corni processing based on back-propagation neural network
, Pharmaceutical Biology 49(9): 989-993 (2011)

Pharmacokinetic parameters of once-daily rilpivirine following administration of efavirenz in healthy subjects
, Antiviral Therapy 17(3): 439-446 (2012)

Pharmacokinetic plasma behaviors of intravenous and oral bioavailability of thymoquinone in a rabbit model
, European Journal of Drug Metabolism and Pharmacokinetics 40(3): 319-323 (2015)

Pharmacokinetic predictions in children by using the physiologically based pharmacokinetic modelling
, Fundamental and Clinical Pharmacology 22(6): 579-587 (2008)

Pharmacokinetic principles of immunosuppressive drugs
, Annals of Transplantation 13(3): 5-10 (2008)

Pharmacokinetic process: does the site of drug action? Excretion of drugs
, Revista de Enfermeria 34(9): 24-31 (2011)

Pharmacokinetic profile and behavioral effects of gabapentin in the horse
, Journal of Veterinary Pharmacology and Therapeutics 33(5): 485-494 (2010)

Pharmacokinetic profile and first preliminary clinical evaluation of bendamustine in Taiwanese patients with heavily pretreated indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
, Hematological Oncology 33(4): 136-144 (2015)

Pharmacokinetic profile and pharmacodynamic effects of romifidine hydrochloride in the horse
, Journal of Veterinary Pharmacology and Therapeutics 35(5): 478-488 (2012)

Pharmacokinetic profile in relation to anaesthesia characteristics after a 5% micellar microemulsion of propofol in the horse
, British Journal of Anaesthesia 104(3): 330-337 (2010)

Pharmacokinetic profile of 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside in mice after oral administration of Polygonum multiflorum extract
, Drug Development and Industrial Pharmacy 38(2): 248-255 (2012)

Pharmacokinetic profile of SKP-1041, a modified release formulation of zaleplon
, Biopharmaceutics and Drug Disposition 32(9): 489-497 (2011)

Pharmacokinetic profile of a 24-hour controlled-release OROS formulation of hydromorphone in the presence of alcohol
, Current Medical Research and Opinion 24(1): 297-305 (2008)

Pharmacokinetic profile of a new formulation of injection diclofenac designed for intradeltoid use
, Expert Opinion on PharmacoTherapy 10(4): 517-522 (2009)

Pharmacokinetic profile of an intradeltoid diclofenac injection in obese Indian volunteers
, Journal of Pain Research 3: 235-240 (2010)

Pharmacokinetic profile of armodafinil in healthy subjects: pooled analysis of data from three randomized studies
, Clinical Drug Investigation 29(2): 87-100 (2009)

Pharmacokinetic profile of bisphosphonates in the treatment of metabolic bone disorders
, Clinical Cases in Mineral and Bone Metabolism 4(1): 30-36 (2007)

Pharmacokinetic profile of dalfampridine extended release: clinical relevance in patients with multiple sclerosis
, Current Medical Research and Opinion 29(12): 1627-1636 (2013)

Pharmacokinetic profile of dextromethorphan hydrobromide in a syrup formulation in children and adolescents
, Clinical Drug Investigation 34(9): 609-616 (2014)

Pharmacokinetic profile of fesoterodine
, International Journal of Clinical Pharmacology and Therapeutics 46(11): 556-563 (2008)

Pharmacokinetic profile of imatinib mesylate and N-desmethyl-imatinib (CGP 74588) in children with newly diagnosed Ph+ acute leukemias
, Cancer ChemoTherapy and Pharmacology 63(3): 563-566 (2009)

Pharmacokinetic profile of immediate-release omeprazole in patients with gastro-oesophageal reflux associated with gastroparesis
, Alimentary Pharmacology and Therapeutics 31(4): 516-522 (2010)

Pharmacokinetic profile of lesogaberan (AZD3355) in healthy subjects: a novel GABA(B)-receptor agonist reflux inhibitor
, Drugs in R&d 11(1): 77-83 (2011)

Pharmacokinetic profile of micafungin when co-administered with amphotericin B in healthy male subjects
, International Journal of Clinical Pharmacology and Therapeutics 52(3): 237-244 (2014)

Pharmacokinetic profile of once-daily cyclobenzaprine extended-release
, Expert Opinion on Drug Metabolism and Toxicology 6(11): 1425-1436 (2010)

Pharmacokinetic profile of spectinomycin in rats
, Die Pharmazie 68(8): 675-676 (2013)

Pharmacokinetic profile of talipexole in healthy volunteers is not altered when it is co-administered with Madopar (co-beneldopa)
, Journal of Clinical Pharmacy and Therapeutics 34(3): 345-354 (2009)

Pharmacokinetic profile of the extended-release formulation of quetiapine fumarate (quetiapine XR): clinical implications
, Current Medical Research and Opinion 29(7): 813-825 (2013)

Pharmacokinetic profile of the fulvestrant loading dose regimen in postmenopausal women with hormone receptor-positive advanced breast cancer
, Clinical Breast Cancer 8(4): 347-351 (2008)

Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo
, Cancer ChemoTherapy and Pharmacology 62(6): 1045-1054 (2008)

Pharmacokinetic profile of total quercetin after single oral dose of tartary buckwheat extracts in rats
, Journal of Agricultural and Food Chemistry 59(9): 4435-4441 (2011)

Pharmacokinetic profile of valganciclovir in pediatric transplant recipients
, Pediatric Infectious Disease Journal 31(4): 405-407 (2012)

Pharmacokinetic profile of voriconazole in a critically ill patient on therapeutic plasma exchange
, Therapeutic Drug Monitoring 35(1): 141-143 (2013)

Pharmacokinetic profiles of a biosimilar filgrastim and Amgen filgrastim: results from a randomized, phase I trial
, Annals of Hematology 89(9): 927-933 (2010)

Pharmacokinetic profiles of anticancer herbal medicines in humans and the clinical implications
, Current Medicinal Chemistry 18(21): 3190-3210 (2011)

Pharmacokinetic profiles of artesunate after single intravenous doses at 0.5, 1, 2, 4, and 8 mg/kg in healthy volunteers: a phase I study
, American Journal of Tropical Medicine and Hygiene 81(4): 615-621 (2009)

Pharmacokinetic profiles of artesunate following multiple intravenous doses of 2, 4, and 8 mg/kg in healthy volunteers: phase 1b study
, Malaria Journal 11: 255 (2012)

Pharmacokinetic profiles of extended release quetiapine fumarate compared with quetiapine immediate release
, Progress in Neuro-Psychopharmacology and Biological Psychiatry 33(2): 199-204 (2009)

Pharmacokinetic profiles of hydrochlorothiazide alone and in combination with benazepril or valsartan in healthy Chinese volunteers: evaluation of the potential interaction
, International Journal of Clinical Pharmacology and Therapeutics 49(12): 756-764 (2011)

Pharmacokinetic profiles of methylprednisolone concentration in perilymph and plasma of guinea pig following local administration
, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 44(10): 853-856 (2009)

Pharmacokinetic profiles of the analgesic drug flupirtine in cats
, Veterinary Journal 202(2): 309-313 (2014)

Pharmacokinetic profiles of the novel COX-2 selective inhibitor cimicoxib in dogs
, Veterinary Journal 200(1): 77-81 (2014)

Pharmacokinetic properties and antitumor efficacy of the 5-fluorouracil loaded PEG-hydrogel
, Bmc Cancer 10: 211 (2010)

Pharmacokinetic properties and bioequivalence of 2 formulations of valsartan 160-mg tablets: A randomized, single-dose, 2-period crossover study in healthy Korean male volunteers
, Clinical Therapeutics 36(2): 273-279 (2014)

Pharmacokinetic properties and bioequivalence of candesartan cilexetil in Korean healthy volunteers
, Drug Development and Industrial Pharmacy 39(9): 1296-1299 (2013)

Pharmacokinetic properties and bioequivalence of olmesartan medoxomil/hydrochlorothiazide in healthy Korean male subjects
, International Journal of Clinical Pharmacology and Therapeutics 52(1): 64-72 (2014)

Pharmacokinetic properties and bioequivalence of two compound formulations of 1500 mg ampicillin (1167 mg)/probenecid (333 mg): a randomized-sequence, single-dose, open-label, two-period crossover study in healthy Chinese male volunteers
, Clinical Therapeutics 32(3): 597-606 (2010)

Pharmacokinetic properties and bioequivalence of two formulations of arbidol: an open-label, single-dose, randomized-sequence, two-period crossover study in healthy Chinese male volunteers
, Clinical Therapeutics 31(4): 784-792 (2009)

Pharmacokinetic properties and bioequivalence of two sulfadoxine/pyrimethamine fixed-dose combination tablets: a parallel-design study in healthy Chinese male volunteers
, Clinical Therapeutics 34(11): 2212-2220 (2012)

Pharmacokinetic properties and effects of PT302 after repeated oral glucose loading tests in a dose-escalating study
, Clinical Therapeutics 36(1): 101-114 (2014)

Pharmacokinetic properties and in silico ADME modeling in drug discovery
, Medicinal Chemistry ) 9(2): 163-176 (2013)

Pharmacokinetic properties and metabolism of a new potent antimalarial N-alkylamidine compound, M64, and its corresponding bioprecursors
, European Journal of Pharmaceutical Sciences 42(1-2): 81-90 (2011)

Pharmacokinetic properties and metabolism of idebenone
, Journal of Neurology 256(Suppl. 1): 31-35 (2009)

Pharmacokinetic properties and systemic safety of vancomycin-impregnated cancellous bone grafts in the treatment of spondylodiscitis
, Biomed Research International 2013: 358217 (2013)

Pharmacokinetic properties and tolerability of bevirimat and atazanavir in healthy volunteers: an open-label, parallel-group study
, Clinical Therapeutics 30(10): 1794-1805 (2008)

Pharmacokinetic properties of 2nd-generation fibroblast growth factor-1 mutants for therapeutic application
, Plos one 7(11): E48210 (2012)

Pharmacokinetic properties of IB1001, an investigational recombinant factor IX, in patients with haemophilia B: repeat pharmacokinetic evaluation and sialylation analysis
, Haemophilia 18(6): 881-887 (2012)

Pharmacokinetic properties of N-nitrosofenfluramine after its administration to rats
, Biomedical Chromatography 25(5): 579-587 (2011)

Pharmacokinetic properties of S-adenosylmethionine after oral and intravenous administration of its tosylate disulfate salt: a multiple-dose, open-label, parallel-group study in healthy Chinese volunteers
, Clinical Therapeutics 31(2): 311-320 (2009)

Pharmacokinetic properties of a 40 kDa branched polyethylene glycol-modified form of consensus interferon-alpha (PEG-CIFN) in rhesus monkeys
, Biopharmaceutics and Drug Disposition 29(8): 481-484 (2008)

Pharmacokinetic properties of albiflorin and paeoniflorin after oral administration of pure compound, Radix Paeoniae alba extract and danggui-shaoyao-san extract to rats
, Journal of Asian Natural Products Research 13(2): 117-127 (2011)

Pharmacokinetic properties of arsenic species after oral administration of Sargassum pallidum extract in rats using an HPLC-HG-AFS method
, Journal of Pharmaceutical and Biomedical Analysis 96: 213-219 (2014)

Pharmacokinetic properties of artemether, dihydroartemisinin, lumefantrine, and quinine in pregnant women with uncomplicated plasmodium falciparum malaria in Uganda
, Antimicrobial Agents and ChemoTherapy 57(10): 5096-5103 (2013)

Pharmacokinetic properties of clarithromycin: A comparison with erythromycin and azithromycin
, Canadian Journal of Infectious Diseases 4(3): 148-152 (1993)

Pharmacokinetic properties of conventional and double-dose sulfadoxine-pyrimethamine given as intermittent preventive treatment in infancy
, Antimicrobial Agents and ChemoTherapy 55(4): 1693-1700 (2011)

Pharmacokinetic properties of delta9-tetrahydrocannabinol in oral fluid of occasional and chronic users
, Journal of Analytical Toxicology 34(4): 216-221 (2010)

Pharmacokinetic properties of delta9-tetrahydrocannabinol in serum and oral fluid
, Journal of Analytical Toxicology 31(5): 288-293 (2007)

Pharmacokinetic properties of hemoglobin vesicles as a substitute for red blood cells
, Drug Metabolism Reviews 43(3): 362-373 (2011)

Pharmacokinetic properties of hydroxysafflor yellow A in healthy Chinese female volunteers
, Journal of Ethnopharmacology 124(3): 635-638 (2009)

Pharmacokinetic properties of indinavir in rat: some limitations of noncompartmental analysis
, Drug Development and Industrial Pharmacy 36(3): 355-361 (2010)

Pharmacokinetic properties of intravitreal I-124-aflibercept in a rabbit model using PET/CT
, Current Eye Research 37(12): 1171-1174 (2012)

Pharmacokinetic properties of isorhamnetin, kaempferol and quercetin after oral gavage of total flavones of Hippophae rhamnoides L. in rats using a UPLC-MS method
, Fitoterapia 83(1): 182-191 (2012)

Pharmacokinetic properties of isradipine after single-dose and multiple-dose oral administration in Chinese volunteers: a randomized, open-label, parallel-group phase I study
, Biomedical Chromatography 27(12): 1664-1670 (2013)

Pharmacokinetic properties of lansoprazole (30-mg enteric-coated capsules) and its metabolites: A single-dose, open-label study in healthy Chinese male subjects
, Current Therapeutic Research Clinical and Experimental 70(3): 228-239 (2009)

Pharmacokinetic properties of lutein emulsion after oral administration to rats and effect of food intake on plasma concentration of lutein
, Biopharmaceutics and Drug Disposition 32(3): 151-158 (2011)

Pharmacokinetic properties of newly synthesized retinoid X receptor agonists possessing a 6-[N-ethyl-N-(3-alkoxy-4-isopropylphenyl)amino]nicotinic acid skeleton in rats
, Drug Development and Industrial Pharmacy 37(9): 1060-1067 (2011)

Pharmacokinetic properties of paeoniflorin, albiflorin and oxypaeoniflorin after oral gavage of extracts of Radix Paeoniae Rubra and Radix Paeoniae Alba in rats
, Journal of Ethnopharmacology 130(2): 407-413 (2010)

Pharmacokinetic properties of recombinant FVIIa in inherited FVII deficiency account for a large volume of distribution at steady state and a prolonged pharmacodynamic effect
, Thrombosis and Haemostasis 112(2): 424-425 (2014)

Pharmacokinetic properties of rituximab
, Reviews on Recent Clinical Trials 3(1): 22-30 (2008)

Pharmacokinetic properties of single-dose lamivudine/adefovir dipivoxil fixed-dose combination in healthy Chinese male volunteers
, Clinical Therapeutics 35(1): 68-76 (2013)

Pharmacokinetic properties of single-dose primaquine in Papua New Guinean children: feasibility of abbreviated high-dose regimens for radical cure of vivax malaria
, Antimicrobial Agents and ChemoTherapy 58(1): 432-439 (2014)

Pharmacokinetic properties of succinylmonocholine in surgical patients
, Journal of Analytical Toxicology 35(5): 302-311 (2011)

Pharmacokinetic properties of sulfadoxine-pyrimethamine in pregnant women
, Antimicrobial Agents and ChemoTherapy 53(10): 4368-4376 (2009)

Pharmacokinetic properties of toceranib phosphate (Palladia, SU11654), a novel tyrosine kinase inhibitor, in laboratory dogs and dogs with mast cell tumors
, Journal of Veterinary Pharmacology and Therapeutics 33(2): 162-171 (2010)

Pharmacokinetic properties of two erlotinib 150 mg formulations with a genetic effect evaluation in healthy Korean subjects
, Clinical Drug Investigation 35(1): 31-43 (2015)

Pharmacokinetic properties of γ-hydroxybutyrate (GHB) in whole blood, serum, and urine
, Journal of Analytical Toxicology 36(2): 88-95 (2012)

Pharmacokinetic properties, potential herb-drug interactions and acute toxicity of oral Rhizoma coptidis alkaloids
, Expert Opinion on Drug Metabolism and Toxicology 9(1): 51-61 (2013)

Pharmacokinetic rationale for dosing every 2 weeks versus 4 weeks with intravitreal ranibizumab, bevacizumab, and aflibercept (vascular endothelial growth factor Trap-eye)
, Retina 32(3): 434-457 (2012)

Pharmacokinetic research in children: an analysis of registered records of clinical trials
, Bmj Open 1(1): E000221 (2011)

Pharmacokinetic research in the early stages of drug discovery-significance and practice
, Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 133(4): 210-213 (2009)

Pharmacokinetic results of a phase I trial of sorafenib in combination with dacarbazine in patients with advanced solid tumors
, Cancer ChemoTherapy and Pharmacology 68(1): 53-61 (2011)

Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2
, European Journal of Pharmaceutical Sciences 35(3): 161-174 (2008)

Pharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipients
, Journal of Pharmacokinetics and Pharmacodynamics 36(6): 541-564 (2009)

Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogs
, European Journal of Pharmaceutical Sciences 40(3): 222-238 (2010)

Pharmacokinetic screening strategy for discovery work-use of rodent species: lessons learnt and probing newer thoughts
, Drug Metabolism and Pharmacokinetics 24(2): 197-198 (2009)

Pharmacokinetic self-potentiation of idarubicin by induction of anthracycline carbonyl reducing enzymes
, Leukemia and Lymphoma 49(4): 809-814 (2008)

Pharmacokinetic simulation of fatal carbamazepine intoxication in 23-month old child following phenytoin discontinuation
, Forensic Science Medicine and Pathology 9(1): 73-76 (2013)

Pharmacokinetic simulations of remifentanil
, Masui. Japanese Journal of Anesthesiology 56(11): 1287-1295 (2007)

Pharmacokinetic simulations to explore dissolution criteria of BCS I and III biowaivers with and without MDR-1 efflux transporter
, European Journal of Pharmaceutical Sciences 61: 18-26 (2014)

Pharmacokinetic strategies for treatment of drug overdose and addiction
, Future Medicinal Chemistry 4(2): 227-243 (2012)

Pharmacokinetic studies and LC-MS/MS method development of ganciclovir and dipeptide monoester prodrugs in Sprague Dawley rats
, European Journal of Drug Metabolism and Pharmacokinetics 40(3): 325-334 (2015)

Pharmacokinetic studies in infants using minimal-risk study designs
, Current Clinical Pharmacology 9(4): 350-358 (2014)

Pharmacokinetic studies in women of 2 novel oral formulations of tranexamic acid therapy for heavy menstrual bleeding
, American Journal of Therapeutics 19(3): 190-198 (2012)

Pharmacokinetic studies of a novel multikinase inhibitor for treating cancer by HPLC-UV
, Journal of Chromatographic Science 51(1): 17-20 (2013)

Pharmacokinetic studies of ceftazidime in serum, bone, bile, tissue fluid and peritoneal fluid
, Journal of Antimicrobial ChemoTherapy 8 Suppl B: 293-297 (1981)

Pharmacokinetic studies of cefuroxime and dosage recommendations in patients with impaired renal function
, Proceedings of the Royal Society of Medicine 70(Suppl 9): 144-147 (1977)

Pharmacokinetic studies of enantiomers of ibuprofen and its chiral metabolites in humans with different variants of genes coding CYP2C8 and CYP2C9 isoenzymes
, Xenobiotica; the Fate of Foreign Compounds in Biological Systems 39(6): 476-485 (2009)

Pharmacokinetic studies of levofloxacin after oral administration in healthy and febrile cow calves
, Veterinary Research Communications 33(8): 887-893 (2009)

Pharmacokinetic studies of metformin and glibenclamide in normal human volunteers
, Pakistan Journal of Pharmaceutical Sciences 27(1): 153-159 (2014)

Pharmacokinetic studies of protein drugs: past, present and future
, Advanced Drug Delivery Reviews 65(8): 1065-1073 (2013)

Pharmacokinetic studies of tetrahydropalmatine and dehydrocorydaline in rat after oral administration of yanhusuo extraction by LC-MS/MS method
, Yao Xue Xue Bao 43(11): 1123-1127 (2008)

Pharmacokinetic studies of vitamin D analogues: relationship to vitamin D binding protein (DBP)
, Endocrine 3(4): 263-266 (1995)

Pharmacokinetic studies of ⁶⁸Ga-labeled Bombesin (⁶⁸Ga-BZH₃) and F-18 FDG PET in patients with recurrent gliomas and comparison to grading: preliminary results
, Clinical Nuclear Medicine 36(2): 101-108 (2011)

Pharmacokinetic study and Fcgamma receptor gene analysis in two patients with rheumatoid arthritis controlled by low-dose infliximab
, Modern Rheumatology 19(3): 329-333 (2009)

Pharmacokinetic study and bioavailability of a novel synthetic trioxane antimalarial compound 97/63 in rats
, Malaria Research and Treatment 2014: 759392 (2014)

Pharmacokinetic study and comparative bioavailability of two nelfinavir tablet formulations in Iranian healthy volunteers after a low-dose administration
, International Journal of Clinical Pharmacology and Therapeutics 47(7): 491-498 (2009)

Pharmacokinetic study and evaluation of the safety of taurolidine for dogs with osteosarcoma
, Journal of Experimental and Clinical Cancer Research 32: 74 (2013)

Pharmacokinetic study for the establishment of bioequivalence of two inhalation treatments containing budesonide plus formoterol
, Journal of Pharmacy and Pharmacology 66(12): 1677-1685 (2014)

Pharmacokinetic study in mice of galphimine-A, an anxiolytic compound from Galphimia glauca
, Molecules 19(3): 3120-3134 (2014)

Pharmacokinetic study in pigs and in vitro metabolic characterization in pig- and human-liver microsomes reveal marked differences in disposition and metabolism of tiletamine and zolazepam (Telazol)
, Xenobiotica; the Fate of Foreign Compounds in Biological Systems 44(4): 379-390 (2014)

Pharmacokinetic study of 3-in-1 poly(ethylene glycol)-block-poly(D, L-lactic acid) micelles carrying paclitaxel, 17-allylamino-17-demethoxygeldanamycin, and rapamycin
, Journal of Controlled Release 163(1): 93-99 (2012)

Pharmacokinetic study of Growth Hormone-Releasing Peptide 6 (GHRP-6) in nine male healthy volunteers
, European Journal of Pharmaceutical Sciences 48(1-2): 40-46 (2013)

Pharmacokinetic study of Guanfu base G in rats by LC-ESI-MS
, Journal of Chromatographic Science 52(9): 1016-1020 (2014)

Pharmacokinetic study of HS061, a new human insulin, in non-diabetic rat using ultra performance liquid chromatography-tandem mass spectrometry
, Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 967: 50-56 (2014)

Pharmacokinetic study of S-1
, International Journal of Clinical Pharmacology and Therapeutics 47(1): 65-67 (2009)

Pharmacokinetic study of S-1 for the treatment of peritoneal metastasis from colon cancer--using a mouse peritoneal metastasis model
, Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(9): 1725-1728 (2010)

Pharmacokinetic study of S-1 in patients in whom inulin clearance was measured
, Oncology 83(1): 38-44 (2012)

Pharmacokinetic study of a carbamazepine nanoemulsion in beagle dogs
, International Journal of Pharmaceutics 378(1-2): 146-148 (2009)

Pharmacokinetic study of a high-purity factor IX concentrate (Factor IX Grifols) with a 6-month follow up in previously treated patients with severe haemophilia B
, Haemophilia 15(6): 1243-1248 (2009)

Pharmacokinetic study of a new angiotensin-AT1 antagonist by HPLC
, Journal of Pharmaceutical and Biomedical Analysis 48(2): 422-427 (2008)

Pharmacokinetic study of a new chewing gum dextromethorphan delivery system
, Nan Fang Yi Ke Da Xue Xue Bao 31(1): 103-107 (2011)

Pharmacokinetic study of a novel recombinant human granulocyte colony-stimulating factor in rats
, Chinese Medical Sciences Journal 25(1): 13-19 (2010)

Pharmacokinetic study of a novel stroke therapeutic, 2-[[(1,1-dimethylethyl)oxidoimino]methyl]-3,5,6-trimethylpyrazine, by a simple HPLC-UV method in rats
, European Journal of Drug Metabolism and Pharmacokinetics 36(2): 95-101 (2011)

Pharmacokinetic study of aldoxorubicin in patients with solid tumors
, Investigational new Drugs 33(2): 341-348 (2015)

Pharmacokinetic study of amoxicillin in human plasma by solid-phase microextraction followed by high-performance liquid chromatography-triple quadrupole mass spectrometry
, Biomedical Chromatography 28(2): 255-264 (2014)

Pharmacokinetic study of amrubicin in a case of small lung cancer on hemodialysis
, Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(8): 1311-1314 (2009)

Pharmacokinetic study of baicalein after oral administration in monkeys
, Fitoterapia 83(3): 532-540 (2012)

Pharmacokinetic study of benfotiamine and the bioavailability assessment compared to thiamine hydrochloride
, Journal of Clinical Pharmacology 54(6): 688-695 (2014)

Pharmacokinetic study of calenduloside E and its active metabolite oleanolic acid in beagle dog using liquid chromatography-tandem mass spectrometry
, Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 951-952: 129-134 (2014)

Pharmacokinetic study of cephradine in Pakistani healthy male volunteers
, Pakistan Journal of Pharmaceutical Sciences 21(4): 400-406 (2008)

Pharmacokinetic study of cinnamaldehyde in rats by GC-MS after oral and intravenous administration
, Journal of Pharmaceutical and Biomedical Analysis 89: 150-157 (2014)

Pharmacokinetic study of conversion from tacrolimus twice-daily to tacrolimus once-daily in stable lung transplantation
, Transplantation 97(3): 358-362 (2014)

Pharmacokinetic study of copper (II) acetylsalicylate
, Biological Trace Element Research 124(3): 283-288 (2008)

Pharmacokinetic study of dual therapy with raltegravir 400 mg twice daily and Darunavir/Ritonavir 800/100 mg once daily in HIV-1-infected patients
, Therapeutic Drug Monitoring 35(4): 552-556 (2013)

Pharmacokinetic study of eight coumarins of Radix Angelicae Dahuricae in rats by gas chromatography-mass spectrometry
, Fitoterapia 89: 250-256 (2013)

Pharmacokinetic study of enclosed hemoglobin and outer lipid component after the administration of hemoglobin vesicles as an artificial oxygen carrier
, Drug Metabolism and Disposition: the Biological Fate of Chemicals 37(7): 1456-1463 (2009)

Pharmacokinetic study of five ginsenosides using a sensitive and rapid liquid chromatography-tandem mass spectrometry method following single and multiple oral administration of Shexiang Baoxin pills to rats
, Biomedical Chromatography 29(3): 425-436 (2015)

Pharmacokinetic study of gemcitabine, given as prolonged infusion at fixed dose rate, in combination with cisplatin in patients with advanced non-small-cell lung cancer
, Cancer ChemoTherapy and Pharmacology 65(6): 1197-1202 (2010)

Pharmacokinetic study of ginsenoside Rc and simultaneous determination of its metabolites in rats using RRLC-Q-TOF-MS
, Journal of Pharmaceutical and Biomedical Analysis 88: 16-21 (2014)

Pharmacokinetic study of hydroxypropylmethylcellulose microparticles loaded with cimetidine
, Advances in Clinical and Experimental Medicine 22(1): 41-45 (2013)

Pharmacokinetic study of interleukin-2 following intravenous injection in hemodialysis patients with renal cell carcinoma
, Therapeutic Apheresis and Dialysis 12(1): 67-71 (2008)

Pharmacokinetic study of lappaconitine hydrobromide in mice by LC-MS
, Yao Xue Xue Bao 46(4): 432-437 (2011)

Pharmacokinetic study of lipoic acid in multiple sclerosis: comparing mice and human pharmacokinetic parameters
, Multiple Sclerosis 16(4): 387-397 (2010)

Pharmacokinetic study of liposome-encapsulated and plain mepivacaine formulations injected intra-orally in volunteers
, Journal of Pharmacy and Pharmacology 64(3): 397-403 (2012)

Pharmacokinetic study of luteolin, apigenin, chrysoeriol and diosmetin after oral administration of Flos Chrysanthemi extract in rats
, Fitoterapia 83(8): 1616-1622 (2012)

Pharmacokinetic study of mangiferin in rat plasma and retina using high-performance liquid chromatography
, Molecular Vision 16: 1659-1668 (2010)

Pharmacokinetic study of minipooled solvent/detergent-filtered cryoprecipitate factor VIII
, Haemophilia 17(5): E884 (2011)

Pharmacokinetic study of mizoribine in child-onset glomerulonephritis
, Pediatrics International 50(5): 615-619 (2008)

Pharmacokinetic study of modafinil in relation to gender and ethnicity in healthy young Chinese volunteers
, Journal of Pharmacy and Pharmaceutical Sciences 13(3): 443-449 (2010)

Pharmacokinetic study of multiple active constituents from Kushen-Gancao Decoction after oral administration in rat by HPLC-MS/MS
, Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 965: 19-26 (2014)

Pharmacokinetic study of mycophenolate mofetil in patients with systemic lupus erythematosus and design of Bayesian estimator using limited sampling strategies
, Clinical Pharmacokinetics 47(4): 277-284 (2008)

Pharmacokinetic study of nicotine and its metabolite cotinine to clarify possible association between smoking and voiding dysfunction in rats using UPLC/ESI-MS
, Drug Metabolism and Pharmacokinetics 26(4): 416-422 (2011)

Pharmacokinetic study of niosome-loaded insulin in diabetic rats
, Daru 19(6): 404-411 (2011)

Pharmacokinetic study of nobiletin and tangeretin in rat serum by high-performance liquid chromatography-electrospray ionization-mass spectrometry
, Journal of Agricultural and Food Chemistry 59(1): 145-151 (2011)

Pharmacokinetic study of once-daily versus twice-daily abacavir and lamivudine in HIV type-1-infected children aged 3-<36 months
, Antiviral Therapy 15(3): 297-305 (2010)

Pharmacokinetic study of polydatin in Beagle dogs
, Nan Fang Yi Ke Da Xue Xue Bao 29(8): 1538-1540 (2009)

Pharmacokinetic study of raltegravir in HIV-infected patients with end-stage liver disease: the LIVERAL-ANRS 148 study
, Clinical Infectious Diseases 59(8): 1177-1184 (2014)

Pharmacokinetic study of rhizoma Curcumae oil and rhizoma Curcumae oil-β-cyclodextrin inclusion complex in pigs after oral administration
, Journal of Veterinary Pharmacology and Therapeutics 35(1): 47-51 (2012)

Pharmacokinetic study of rosuvastatin in males and females
, European Journal of Drug Metabolism and Pharmacokinetics 40(3): 313-318 (2015)

Pharmacokinetic study of saquinavir 500 mg plus ritonavir (1000/100 mg twice a day) in HIV-positive pregnant women
, Therapeutic Drug Monitoring 33(6): 772-777 (2011)

Pharmacokinetic study of saxagliptin in healthy Chinese subjects
, Clinical Drug Investigation 32(7): 465-473 (2012)

Pharmacokinetic study of schisandrin, schisandrol B, schisantherin A, deoxyschisandrin, and schisandrin B in rat plasma after oral administration of Shengmaisan formula by UPLC-MS
, Journal of Separation Science 36(3): 485-491 (2013)

Pharmacokinetic study of single and multiple oral dose administration of antofloxacin hydrochloride in healthy male volunteers
, Chinese Medical Journal 124(2): 242-245 (2011)

Pharmacokinetic study of six aconitine alkaloids in aconiti lateralis radix praeparata in beagle dogs
, Zhong Yao Cai 37(2): 284-287 (2014)

Pharmacokinetic study of six flavones in rat plasma and tissues after oral administration of 'JiangYaBiFeng' using SPE-HPLC-DAD
, Journal of Pharmaceutical and Biomedical Analysis 56(4): 815-819 (2011)

Pharmacokinetic study of sodium trans[tetrachlorobis(1H-indazole)-ruthenate (III)]/-indazole hydrochloride (1:1.1) (FFC14A) in patients with solid tumors
, International Journal of Clinical Pharmacology and Therapeutics 47(1): 58-60 (2009)

Pharmacokinetic study of sulbactomax
, Journal of Toxicological Sciences 35(4): 459-464 (2010)

Pharmacokinetic study of temozolomide on a daily-for-5-days schedule in Japanese patients with relapsed malignant gliomas: first study in Asians
, International Journal of Clinical Oncology 12(5): 341-349 (2007)

Pharmacokinetic study of the oral administration of procaterol hydrochloride hydrate 50 µg in healthy adult Japanese men
, International Journal of Clinical Pharmacology and Therapeutics 48(11): 744-750 (2010)

Pharmacokinetic study of the phase III, randomized, double-blind, multicenter trial (TRIBUTE) of paclitaxel and carboplatin combined with erlotinib or placebo in patients with advanced Non-small Cell Lung Cancer (NSCLC)
, Investigational new Drugs 29(3): 499-505 (2011)

Pharmacokinetic study of the structural components of adenosine diphosphate-encapsulated liposomes coated with fibrinogen γ-chain dodecapeptide as a synthetic platelet substitute
, Drug Metabolism and Disposition: the Biological Fate of Chemicals 41(8): 1584-1591 (2013)

Pharmacokinetic study of the variability of indinavir drug levels when boosted with ritonavir in HIV-infected children
, Pharmacology 83(1): 59-66 (2009)

Pharmacokinetic study of three cardiovascular drugs by high-performance liquid chromatography using pre-column derivatization with 9,10-anthraquinone-2-sulfonyl chloride
, Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 858(1-2): 42-48 (2007)

Pharmacokinetic study of trans-resveratrol in adult pigs
, Journal of Agricultural and Food Chemistry 58(20): 11165-11171 (2010)

Pharmacokinetic study of two acetylcholinesterase reactivators, trimedoxime and newly synthesized oxime K027, in rat plasma
, Journal of Applied Toxicology 33(1): 18-23 (2013)

Pharmacokinetic study of vitreous and serum concentrations of triamcinolone acetonide after posterior sub-tenon's injection
, American Journal of Ophthalmology 153(5): 939-948 (2012)

Pharmacokinetic study of weekly (days 1-5) low-dose S-1 in patients with non-small-cell lung cancer
, Reviews on Recent Clinical Trials 7(2): 167-172 (2012)

Pharmacokinetic study on acetoside in rats
, Zhongguo Zhong Yao Za Zhi 37(21): 3312-3315 (2012)

Pharmacokinetic study on baicalin of Qingkailing injection in rats
, Zhongguo Zhong Yao Za Zhi 32(23): 2534-2538 (2007)

Pharmacokinetic study on costunolide and dehydrocostuslactone after oral administration of traditional medicine Aucklandia lappa Decne. by LC/MS/MS
, Journal of Ethnopharmacology 151(1): 191-197 (2014)

Pharmacokinetic study on peoniflorin, astilbin, rosmarinic acid, isofraxidin and liquiritin in rat blood after oral administration of shaolin xiaoyin tablets
, Zhongguo Zhong Yao Za Zhi 39(13): 2559-2563 (2014)

Pharmacokinetic study on pradofloxacin in the dog - comparison of serum analysis, ultrafiltration and tissue sampling after oral administration
, Bmc Veterinary Research 9: 32 (2013)

Pharmacokinetic study on the mechanism of interaction of sulfacetamide sodium with bovine serum albumin: a spectroscopic method
, Biopharmaceutics and Drug Disposition 31(2-3): 120-128 (2010)

Pharmacokinetic study on three main ingredients of refined coronary cataplasm
, Zhongguo Zhong Yao Za Zhi 37(23): 3641-3646 (2012)

Pharmacokinetic study to compare the absorption and tolerability of two doses of levonorgestrel following single vaginal administration of levonorgestrel in Carraguard gel: a new formulation for "dual protection" contraception
, Contraception 75(6): 454-460 (2007)

Pharmacokinetic study to optimize the intravesical administration of gemcitabine
, Bju International 106(11): 1652-1656 (2010)

Pharmacokinetic sub-study in the SPIRIT III Randomized and Controlled Trial of XIENCE V everolimus eluting coronary stent system
, Journal of Interventional Cardiology 23(1): 26-32 (2010)

Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia
, Journal of Hematology and Oncology 3: 36 (2010)

Pharmacokinetic tools for the dose adjustment of ciclosporin in haematopoietic stem cell transplant patients
, British Journal of Clinical Pharmacology 78(4): 836-846 (2014)

Pharmacokinetic variability and modern epidemiology--the example of dichlorodiphenyltrichloroethane, body mass index, and birth cohort
, Cancer Epidemiology Biomarkers and Prevention 16(10): 1925-1930 (2007)

Pharmacokinetic variability of amikacin after once-daily and twice-daily dosing regimen in full-term neonates
, Journal of Pharmacological Sciences 124(2): 138-143 (2014)

Pharmacokinetic variability of anthelmintics: implications for the treatment of neurocysticercosis
, Expert Review of Clinical Pharmacology 5(1): 21-30 (2012)

Pharmacokinetic variability of antiretroviral drugs and correlation with virological outcome: 2 years of experience in routine clinical practice
, Journal of Antimicrobial ChemoTherapy 64(1): 109-117 (2009)

Pharmacokinetic variability of clarithromycin and differences in CYP3A4 activity in patients with cystic fibrosis
, Journal of Cystic Fibrosis 13(2): 179-185 (2014)

Pharmacokinetic variability of extended interval tobramycin in burn patients
, Burns 34(6): 791-796 (2008)

Pharmacokinetic variability of flecainide in younger Japanese patients and mechanisms for renal excretion and intestinal absorption
, Biopharmaceutics and Drug Disposition 35(3): 145-153 (2014)

Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication
, Therapeutic Drug Monitoring 34(4): 440-445 (2012)

Pharmacokinetic variability of long-acting stimulants in the treatment of children and adults with attention-deficit hyperactivity disorder
, Cns Drugs 24(12): 1009-1025 (2010)

Pharmacokinetic variability of mycophenolic acid and its glucuronide in systemic lupus erythematosus patients in remission maintenance phase
, Biological and Pharmaceutical Bulletin 34(5): 755-759 (2011)

Pharmacokinetic variability of quetiapine and the active metabolite N-desalkylquetiapine in psychiatric patients
, Therapeutic Drug Monitoring 33(2): 222-226 (2011)

Pharmacokinetic variability of voriconazole and N-oxide voriconazole measured as therapeutic drug monitoring
, Xenobiotica; the Fate of Foreign Compounds in Biological Systems 40(10): 701-706 (2010)

Pharmacokinetic variation of ofloxacin based on gender-related difference in the expression of multidrug resistance-associated protein (Abcc2/Mrp2) in rat kidney
, Yao Xue Xue Bao 47(5): 624-629 (2012)

Pharmacokinetic variations of tetramethylpyrazine phosphate after oral administration in hepatic precancerous mice and its hepatoprotective effects
, Drug Development and Industrial Pharmacy 40(1): 1-8 (2014)

Pharmacokinetic(s) matters: stroke treatment et cetera
, British Journal of Clinical Pharmacology 65(3): 299-300 (2008)

Pharmacokinetic, biodistribution, and biophysical profiles of TNF nanobodies conjugated to linear or branched poly(ethylene glycol)
, Bioconjugate Chemistry 23(7): 1452-1462 (2012)

Pharmacokinetic, distribution, metabolism, and excretion of (Z)-2-amino-1,5-dihydro-1-methyl-5-[4-(mesyl)benzylidene]-4H-imidazol-4-one mesilate (ZLJ-601) in Sprague-Dawley rats
, Pharmacology 89(3-4): 192-200 (2012)

Pharmacokinetic, pharmacodynamic and clinical evaluation of aliskiren for hypertension treatment
, Expert Opinion on Drug Metabolism and Toxicology 7(1): 115-128 (2011)

Pharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseases
, British Journal of Pharmacology 159(3): 502-517 (2010)

Pharmacokinetic, pharmacodynamic and immunogenicity comparability assessment strategies for monoclonal antibodies
, Trends in Biotechnology 28(10): 509-516 (2010)

Pharmacokinetic, pharmacodynamic and pharmacogenetic profile of the oral antiplatelet agent ticagrelor
, Clinical Pharmacokinetics 51(5): 305-318 (2012)

Pharmacokinetic, pharmacodynamic, and efficacy profiles of alogliptin, a novel inhibitor of dipeptidyl peptidase-4, in rats, dogs, and monkeys
, European Journal of Pharmacology 589(1-3): 306-314 (2008)

Pharmacokinetic, pharmacodynamic, and electrocardiographic effects of dapoxetine and moxifloxacin compared with placebo in healthy adult male subjects
, Journal of Clinical Pharmacology 49(6): 634-642 (2009)

Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia
, Blood 117(8): 2340 (2011)

Pharmacokinetic, pharmacodynamic, and safety/tolerability profiles of CG100649, a novel COX-2 inhibitor: results of a phase i, randomized, multiple-dose study in healthy Korean men and women
, Clinical Therapeutics 37(1): 197-210 (2015)

Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptin: a randomized, double-blind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes
, Clinical Therapeutics 30(3): 499-512 (2008)

Pharmacokinetic, pharmacodynamic, efficacy, and safety data from two randomized, double-blind studies in patients with asthma and an in vitro study comparing two dry-powder inhalers delivering a combination of salmeterol 50 microg and fluticasone propionate 250 microg: implications for establishing bioequivalence of inhaled products
, Clinical Therapeutics 31(2): 370-385 (2009)

Pharmacokinetic, tissue distribution and excretion of ginsenoside-Rd in rodents
, Phytomedicine 19(3-4): 369-373 (2012)

Pharmacokinetic, tolerability, and bioequivalence comparison of three different intravenous formulations of recombinant human erythropoietin in healthy Korean adult male volunteers: an open-label, randomized-sequence, three-treatment, three-way crossover study
, Clinical Therapeutics 31(5): 1046-1053 (2009)

Pharmacokinetic, toxicological and phototherapeutic studies of phthalocyanine ZnPcCF3
, Biomedicine and PharmacoTherapy 63(3): 209-215 (2009)

Pharmacokinetic- and pharmacodynamic-based antithrombotic dosing recommendations in children
, Expert Review of Clinical Pharmacology 5(4): 389-396 (2012)

Pharmacokinetic- pharmacodynamic analysis of the role of CYP2C19 genotypes in short-term rabeprazole-based triple therapy against Helicobacter pylori
, British Journal of Clinical Pharmacology 67(5): 503-510 (2009)

Pharmacokinetic-Pharmacodynamic Modeling of Metformin for the Treatment of Type II Diabetes Mellitus
, Open Biomedical Engineering Journal 5: 1-7 (2011)

Pharmacokinetic-directed dosing of vandetanib and docetaxel in a mouse model of human squamous cell carcinoma
, Molecular Cancer Therapeutics 7(9): 3006-3017 (2008)

Pharmacokinetic-directed high-dose busulfan combined with cyclophosphamide and etoposide results in predictable drug levels and durable long-term survival in lymphoma patients undergoing autologous stem cell transplantation
, Biology of Blood and Marrow Transplantation 18(8): 1287-1294 (2012)

Pharmacokinetic-interaction of Vitex negundo Linn. & paracetamol
, Indian Journal of Medical Research 130(4): 479-483 (2009)

Pharmacokinetic-pharmacodynamic (PK-PD) modeling and simulation of 5-fluorouracil for erythropenia in rats
, Journal of Pharmacological and Toxicological Methods 70(2): 134-144 (2014)

Pharmacokinetic-pharmacodynamic (PK-PD) modeling and the rational selection of dosage regimes for the prudent use of antimicrobial drugs
, Veterinary Microbiology 171(3-4): 480-486 (2014)

Pharmacokinetic-pharmacodynamic analyses for efficacy of ceftaroline fosamil in patients with community-acquired bacterial pneumonia
, Antimicrobial Agents and ChemoTherapy 57(12): 6348-6350 (2013)

Pharmacokinetic-pharmacodynamic analysis for efficacy of ceftaroline fosamil in patients with acute bacterial skin and skin structure infections
, Antimicrobial Agents and ChemoTherapy 59(1): 372-380 (2015)

Pharmacokinetic-pharmacodynamic analysis of azithromycin extended release in Japanese patients with common respiratory tract infectious disease
, Journal of Antimicrobial ChemoTherapy 66(1): 165-174 (2011)

Pharmacokinetic-pharmacodynamic analysis of the static allodynia response to pregabalin and sildenafil in a rat model of neuropathic pain
, Journal of Pharmacology and Experimental Therapeutics 334(2): 599-608 (2010)

Pharmacokinetic-pharmacodynamic analysis of vismodegib in preclinical models of mutational and ligand-dependent Hedgehog pathway activation
, Clinical Cancer Research 17(14): 4682-4692 (2011)

Pharmacokinetic-pharmacodynamic and response sensitization modeling of the intraocular pressure-lowering effect of the EP4 Agonist 5-{3-[(2S)-2-{(3R)-3-hydroxy-4-[3-(trifluoromethyl)phenyl]butyl}-5-oxopyrrolidin-1-yl]propyl}thiophene-2-carboxylate (PF-04475270)
, Journal of Pharmacology and Experimental Therapeutics 331(2): 627-635 (2009)

Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model
, Antimicrobial Agents and ChemoTherapy 54(5): 1678-1683 (2010)

Pharmacokinetic-pharmacodynamic assessment of tacrolimus in liver-transplant recipients during the early post-transplantation period
, Therapeutic Drug Monitoring 30(4): 412-418 (2008)

Pharmacokinetic-pharmacodynamic assessment of topiramate dosing regimens for children with epilepsy 2 to <10 years of age
, Epilepsia 51(10): 1954-1962 (2010)

Pharmacokinetic-pharmacodynamic considerations in the design of hospital-acquired or ventilator-associated bacterial pneumonia studies: look before you leap!
, Clinical Infectious Diseases 51(Suppl. 1): S103 (2010)

Pharmacokinetic-pharmacodynamic crisis in the elderly
, American Journal of Therapeutics 14(5): 488-498 (2007)

Pharmacokinetic-pharmacodynamic crossover comparison of two levodopa extension strategies
, Movement Disorders 24(9): 1319-1324 (2009)

Pharmacokinetic-pharmacodynamic disease progression model for effect of etanercept in Lewis rats with collagen-induced arthritis
, Pharmaceutical Research 28(7): 1622-1630 (2011)

Pharmacokinetic-pharmacodynamic equivalence of three gliclazide formulations in healthy human male subjects
, International Journal of Clinical Pharmacology and Therapeutics 49(7): 444-450 (2011)

Pharmacokinetic-pharmacodynamic evaluation of the major component astragaloside IV on the immunomodulatory effects of Yu-ping-feng prescription
, European Journal of Drug Metabolism and Pharmacokinetics 39(2): 103-110 (2014)

Pharmacokinetic-pharmacodynamic indices of enrofloxacin in Escherichia coli O78/H12 infected chickens
, Food and Chemical Toxicology 49(7): 1530-1536 (2011)

Pharmacokinetic-pharmacodynamic integration and modelling of florfenicol in calves
, Journal of Veterinary Pharmacology and Therapeutics 37(3): 231-242 (2014)

Pharmacokinetic-pharmacodynamic integration of orbifloxacin in Japanese quail (Coturnix japonica) following oral and intravenous administration
, Journal of Veterinary Pharmacology and Therapeutics 34(4): 350-358 (2011)

Pharmacokinetic-pharmacodynamic interaction between nebicapone and controlled-release levodopa/benserazide: a single-center, Phase I, double-blind, randomized, placebo-controlled, four-way crossover study in healthy subjects
, Clinical Therapeutics 31(10): 2258-2271 (2009)

Pharmacokinetic-pharmacodynamic interaction between nebicapone, a novel catechol-o-methyltransferase inhibitor, and controlled-release levodopa/carbidopa 200 mg/50 mg : randomized, double-blind, placebo-controlled, crossover study in healthy subjects
, Drugs in R&d 9(6): 435-446 (2008)

Pharmacokinetic-pharmacodynamic model for the reversal of neuromuscular blockade by sugammadex
, Anesthesiology 110(1): 95-105 (2009)

Pharmacokinetic-pharmacodynamic model of the antihypertensive interaction between telmisartan and hydrochlorothiazide in spontaneously hypertensive rats
, Journal of Pharmacy and Pharmacology 66(8): 1112-1121 (2014)

Pharmacokinetic-pharmacodynamic modeling and simulation for bactericidal effect in an in vitro dynamic model
, Journal of Pharmaceutical Sciences 97(9): 4108-4117 (2008)

Pharmacokinetic-pharmacodynamic modeling for reduction of hepatic apolipoprotein B mRNA and plasma total cholesterol after administration of antisense oligonucleotide in mice
, Journal of Pharmacokinetics and Pharmacodynamics 42(1): 67-77 (2015)

Pharmacokinetic-pharmacodynamic modeling in acute and chronic pain: an overview of the recent literature
, Expert Review of Clinical Pharmacology 4(6): 719-728 (2011)

Pharmacokinetic-pharmacodynamic modeling in anesthesia, intensive care and pain medicine
, Current Opinion in Anaesthesiology 22(4): 463-468 (2009)

Pharmacokinetic-pharmacodynamic modeling in overdose patients - is it worth the trouble?
, Clinical Toxicology 48(9): 896-897 (2010)

Pharmacokinetic-pharmacodynamic modeling of QRS-prolongation by flecainide: heart rate-dependent effects during sinus rhythm in conscious telemetered dogs
, Journal of Pharmacological and Toxicological Methods 69(1): 24-29 (2014)

Pharmacokinetic-pharmacodynamic modeling of alpha interferon response induced by a Toll-like 7 receptor agonist in mice
, Antimicrobial Agents and ChemoTherapy 54(3): 1179-1185 (2010)

Pharmacokinetic-pharmacodynamic modeling of apratastat: a population-based approach
, Journal of Clinical Pharmacology 51(4): 472-481 (2011)

Pharmacokinetic-pharmacodynamic modeling of biomarker response and tumor growth inhibition to an orally available heat shock protein 90 inhibitor in a human tumor xenograft mouse model
, Journal of Pharmacology and Experimental Therapeutics 338(3): 964-973 (2011)

Pharmacokinetic-pharmacodynamic modeling of dalbavancin, a novel glycopeptide antibiotic
, Journal of Clinical Pharmacology 48(9): 1063-1068 (2008)

Pharmacokinetic-pharmacodynamic modeling of diltiazem in spontaneously hypertensive rats: a microdialysis study
, Journal of Pharmacological and Toxicological Methods 56(3): 290-299 (2007)

Pharmacokinetic-pharmacodynamic modeling of fostamatinib efficacy on ACR20 to support dose selection in patients with rheumatoid arthritis (RA)
, Journal of Clinical Pharmacology 55(3): 328-335 (2015)

Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease
, Clinical Neuropharmacology 33(3): 135-141 (2010)

Pharmacokinetic-pharmacodynamic modeling of manganese after a single intravenous infusion of mangafodipir in patients with acute alcoholic hepatitis
, Therapeutic Drug Monitoring 31(5): 557-565 (2009)

Pharmacokinetic-pharmacodynamic modeling of methylxanthine derivatives in mice challenged with high-dose lipopolysaccharide
, Pharmacology 85(5): 264-271 (2010)

Pharmacokinetic-pharmacodynamic modeling of mood and withdrawal symptoms in relation to plasma concentrations of methadone in patients undergoing methadone maintenance treatment
, Journal of Clinical Psychopharmacology 32(5): 666-671 (2012)

Pharmacokinetic-pharmacodynamic modeling of propofol in children
, Anesthesiology 113(2): 343-352 (2010)

Pharmacokinetic-pharmacodynamic modeling of rifampicin-mediated Cyp3a11 induction in steroid and xenobiotic X receptor humanized mice
, Journal of Pharmacology and Experimental Therapeutics 337(1): 75-82 (2011)

Pharmacokinetic-pharmacodynamic modeling of the D₂ and 5-HT (2A) receptor occupancy of risperidone and paliperidone in rats
, Pharmaceutical Research 29(7): 1932-1948 (2012)

Pharmacokinetic-pharmacodynamic modeling of the antihypertensive effect of eprosartan in Black and White hypertensive patients
, Clinical Pharmacokinetics 52(9): 793-803 (2013)

Pharmacokinetic-pharmacodynamic modeling of the effect of propofol on alpha 1-adrenoceptor-mediated positive inotropy in rat heart
, European Journal of Pharmaceutical Sciences 38(4): 389-394 (2009)

Pharmacokinetic-pharmacodynamic modeling of the effect of varenicline on nicotine craving in adult smokers
, Nicotine and Tobacco Research 17(1): 106-113 (2015)

Pharmacokinetic-pharmacodynamic modeling of the hypotensive effect of remifentanil in infants undergoing cranioplasty
, Paediatric Anaesthesia 20(1): 7-18 (2010)

Pharmacokinetic-pharmacodynamic modeling of the in vitro activities of oxazolidinone antimicrobial agents against methicillin-resistant Staphylococcus aureus
, Antimicrobial Agents and ChemoTherapy 53(12): 5039-5045 (2009)

Pharmacokinetic-pharmacodynamic modeling of the inhibitory effects of naproxen on the time-courses of inflammatory pain, fever, and the ex vivo synthesis of TXB2 and PGE2 in rats
, Pharmaceutical Research 28(7): 1561-1576 (2011)

Pharmacokinetic-pharmacodynamic modeling of tumor growth inhibition and biomarker modulation by the novel phosphatidylinositol 3-kinase inhibitor GDC-0941
, Drug Metabolism and Disposition: the Biological Fate of Chemicals 38(9): 1436-1442 (2010)

Pharmacokinetic-pharmacodynamic modeling to support doripenem dose regimen optimization for critically ill patients
, Diagnostic Microbiology and Infectious Disease 63(4): 409-414 (2009)

Pharmacokinetic-pharmacodynamic modelling in anaesthesia
, British Journal of Clinical Pharmacology 79(1): 72-84 (2015)

Pharmacokinetic-pharmacodynamic modelling of antibiotic therapy in severe sepsis
, Anaesthesiology Intensive Therapy 44(3): 158-164 (2012)

Pharmacokinetic-pharmacodynamic modelling of biomarker response to sitagliptin in healthy volunteers
, Basic and Clinical Pharmacology and Toxicology 113(2): 113-125 (2013)

Pharmacokinetic-pharmacodynamic modelling of intravenous and oral topiramate and its effect on phonemic fluency in adult healthy volunteers
, British Journal of Clinical Pharmacology 79(5): 820-830 (2015)

Pharmacokinetic-pharmacodynamic modelling of intravenous buprenorphine in conscious horses
, Veterinary Anaesthesia and Analgesia 42(1): 17-29 (2015)

Pharmacokinetic-pharmacodynamic modelling of ketamine in six neurotraumatised intensive care patients
, Clinical Drug Investigation 23(9): 605-609 (2003)

Pharmacokinetic-pharmacodynamic modelling of opioids in healthy human volunteers. a minireview
, Basic and Clinical Pharmacology and Toxicology 110(3): 219-226 (2012)

Pharmacokinetic-pharmacodynamic modelling of the analgesic and antihyperalgesic effects of morphine after intravenous infusion in human volunteers
, Basic and Clinical Pharmacology and Toxicology 115(3): 257-267 (2014)

Pharmacokinetic-pharmacodynamic modelling of the analgesic effects of lumiracoxib, a selective inhibitor of cyclooxygenase-2, in rats
, British Journal of Pharmacology 159(1): 176-187 (2010)

Pharmacokinetic-pharmacodynamic modelling of the antihistaminic (H1) effect of bilastine
, Clinical Pharmacokinetics 48(8): 543-554 (2009)

Pharmacokinetic-pharmacodynamic modelling of the effect of Moxifloxacin on QTc prolongation in telemetered cynomolgus monkeys
, Journal of Pharmacological and Toxicological Methods 63(3): 304-313 (2011)

Pharmacokinetic-pharmacodynamic models for inhaled anaesthetics
, Der Anaesthesist 56(6): 538-556 (2007)

Pharmacokinetic-pharmacodynamic profiling of four antimicrobials against gram-negative bacteria collected from Shenyang, China
, Bmc Infectious Diseases 10: 171 (2010)

Pharmacokinetic-pharmacodynamic reasoning in drug discovery and early development
, Future Medicinal Chemistry 1(8): 1371-1374 (2009)

Pharmacokinetic-pharmacodynamic relationship of NRTIs and its connection to viral escape: an example based on zidovudine
, European Journal of Pharmaceutical Sciences 36(4-5): 532-543 (2009)

Pharmacokinetic-pharmacodynamic relationships of central nervous system effects of scopolamine in healthy subjects
, British Journal of Clinical Pharmacology 71(6): 886-898 (2011)

Pharmacokinetic-pharmacodynamic relationships of macitentan, a new endothelin receptor antagonist, after multiple dosing in healthy Korean subjects
, American Journal of Cardiovascular Drugs 14(5): 377-385 (2014)

Pharmacokinetic-pharmacodynamic studies of the 11β-hydroxysteroid dehydrogenase type 1 inhibitor MK-0916 in healthy subjects
, British Journal of Clinical Pharmacology 76(6): 917-931 (2013)

Pharmacokinetic-pharmacodynamic study of itraconazole in patients with fungal infections in intensive care units
, Journal of Infection and ChemoTherapy 17(2): 224-230 (2011)

Pharmacokinetic-pharmacodynamic study of subcutaneous injection of depot nandrolone decanoate using dried blood spots sampling coupled with ultrapressure liquid chromatography tandem mass spectrometry assays
, Journal of Clinical Endocrinology and Metabolism 99(7): 2592-2598 (2014)

Pharmacokinetic-pharmacodynamic target attainment analyses to evaluate in vitro susceptibility test interpretive criteria for ceftaroline against Staphylococcus aureus and Streptococcus pneumoniae
, Antimicrobial Agents and ChemoTherapy 58(2): 885-891 (2014)

Pharmacokinetic-pharmacodynamic target attainment analysis of biapenem in adult patients: a dosing strategy
, ChemoTherapy 54(5): 386-394 (2008)

Pharmacokinetic-pharmacodynamic target attainment analysis of doripenem in infected patients
, International Journal of Antimicrobial Agents 33(3): 276-279 (2009)

Pharmacokinetic-pharmacodynamic values for amoxicillin in pigs
, American Journal of Veterinary Research 75(4): 316 (2014)

Pharmacokinetic-pharmacodynamic-model-guided doripenem dosing in critically ill patients
, Antimicrobial Agents and ChemoTherapy 54(6): 2360-2364 (2010)

Pharmacokinetic-pharmacodynamics relationships of imatinib (Glivec)
, Therapie 62(2): 87-90 (2007)

Pharmacokinetic/ pharmacodynamic-driven drug development
, Mount Sinai Journal of Medicine new York 77(4): 381-388 (2010)

Pharmacokinetic/Pharmacodynamic Analysis of a Hemodialyzed Patient Treated with 25 mg of Sunitinib
, Case Reports in Oncology 5(3): 627-632 (2012)

Pharmacokinetic/Pharmacodynamic antimicrobial individualization and optimization strategies
, Current Infectious Disease Reports 10(1): 9-13 (2008)

Pharmacokinetic/Pharmacodynamic modeling of abexinostat-induced thrombocytopenia across different patient populations: application for the determination of the maximum tolerated doses in both lymphoma and solid tumour patients
, Investigational new Drugs 32(5): 985-994 (2014)

Pharmacokinetic/pharmacodynamic (PK/PD) considerations in the management of Gram-positive bacteraemia
, International Journal of Antimicrobial Agents 36(Suppl. 2): S33 (2010)

Pharmacokinetic/pharmacodynamic (PK/PD) differentiation of native and PEGylated recombinant human growth hormone (rhGH and PEG-rhGH) in the rat model of osteoarthritis
, Xenobiotica; the Fate of Foreign Compounds in Biological Systems 40(8): 586-592 (2010)

Pharmacokinetic/pharmacodynamic analysis in microbiology: a tool for the evaluation of the antimicrobial treatment
, Enfermedades Infecciosas y Microbiologia Clinica 33(1): 48-57 (2015)

Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon α-2b in patients with resected high-risk melanoma
, Cancer ChemoTherapy and Pharmacology 67(3): 657-666 (2011)

Pharmacokinetic/pharmacodynamic analysis of the influence of inoculum size on the selection of resistance in Escherichia coli by a quinolone in a mouse thigh bacterial infection model
, Antimicrobial Agents and ChemoTherapy 53(8): 3384-3390 (2009)

Pharmacokinetic/pharmacodynamic assessment of the effects of parenteral administration of a fluoroquinolone on the intestinal microbiota: comparison of bactericidal activity at the gut versus the systemic level in a pig model
, International Journal of Antimicrobial Agents 42(5): 429-435 (2013)

Pharmacokinetic/pharmacodynamic drug interaction between rosiglitazone and mycophenolate mofetil in kidney transplantation: a case report
, Transplantation 85(6): 921-922 (2008)

Pharmacokinetic/pharmacodynamic evaluation of amoxicillin, amoxicillin/clavulanate and ceftriaxone in the treatment of paediatric acute otitis media in Spain
, Enfermedades Infecciosas y Microbiologia Clinica 29(3): 167-173 (2011)

Pharmacokinetic/pharmacodynamic evaluation of linezolid in hospitalized paediatric patients: a step toward dose optimization by means of therapeutic drug monitoring and Monte Carlo simulation
, Journal of Antimicrobial ChemoTherapy 70(1): 198-206 (2015)

Pharmacokinetic/pharmacodynamic evaluation of marbofloxacin in the treatment of Haemophilus parasuis and Actinobacillus pleuropneumoniae infections in nursery and fattener pigs using Monte Carlo simulations
, Journal of Veterinary Pharmacology and Therapeutics 37(6): 542-549 (2014)

Pharmacokinetic/pharmacodynamic evaluation of rasagiline mesylate for Parkinson's disease
, Expert Opinion on Drug Metabolism and Toxicology 10(10): 1423-1432 (2014)

Pharmacokinetic/pharmacodynamic evaluation of sulbactam against Acinetobacter baumannii in in vitro and murine thigh and lung infection models
, International Journal of Antimicrobial Agents 43(6): 547-552 (2014)

Pharmacokinetic/pharmacodynamic evaluation of the efficacy of flumequine in treating colibacillosis in turkeys
, Poultry Science 92(12): 3158-3165 (2013)

Pharmacokinetic/pharmacodynamic indices: are we ready to use them in daily practice?
, Expert Review of Anti-Infective Therapy 5(6): 913-916 (2007)

Pharmacokinetic/pharmacodynamic investigation of colistin against Pseudomonas aeruginosa using an in vitro model
, Antimicrobial Agents and ChemoTherapy 54(9): 3783-3789 (2010)

Pharmacokinetic/pharmacodynamic model-based combination therapy approach to target antibiotic resistant populations emerged from ciprofloxacin exposure
, Die Pharmazie 65(6): 417-420 (2010)

Pharmacokinetic/pharmacodynamic modeling and simulation of neutropenia during phase I development of liposome-entrapped paclitaxel
, Clinical Cancer Research 14(18): 5856-5863 (2008)

Pharmacokinetic/pharmacodynamic modeling and simulation of rosuvastatin using an extension of the indirect response model by incorporating a circadian rhythm
, Biological and Pharmaceutical Bulletin 33(6): 1082-1087 (2010)

Pharmacokinetic/pharmacodynamic modeling and simulation to determine effective dosage regimens for doripenem
, Journal of Pharmaceutical Sciences 99(5): 2483-2491 (2010)

Pharmacokinetic/pharmacodynamic modeling for concentration-dependent bactericidal activity of a bicyclolide, modithromycin
, Journal of Pharmaceutical Sciences 103(4): 1288-1297 (2014)

Pharmacokinetic/pharmacodynamic modeling for the determination of a cimicoxib dosing regimen in the dog
, Bmc Veterinary Research 9: 250 (2013)

Pharmacokinetic/pharmacodynamic modeling identifies SN30000 and SN29751 as tirapazamine analogues with improved tissue penetration and hypoxic cell killing in tumors
, Clinical Cancer Research 16(20): 4946-4957 (2010)

Pharmacokinetic/pharmacodynamic modeling in inflammation
, Critical Reviews in Biomedical Engineering 40(4): 295-312 (2012)

Pharmacokinetic/pharmacodynamic modeling of antipyretic and reducing plasma concentration of NO effects of Rheum palmatum in rat
, Zhongguo Zhong Yao Za Zhi 38(8): 1231-1236 (2013)

Pharmacokinetic/pharmacodynamic modeling of cardiac toxicity in human acute overdoses: utility and limitations
, Expert Opinion on Drug Metabolism and Toxicology 4(5): 569-579 (2008)

Pharmacokinetic/pharmacodynamic modeling of corticosterone suppression and lymphocytopenia by methylprednisolone in rats
, Journal of Pharmaceutical Sciences 97(7): 2820-2832 (2008)

Pharmacokinetic/pharmacodynamic modeling of glucose clamp effects of inhaled and subcutaneous insulin in healthy volunteers and diabetic patients
, Drug Metabolism and Pharmacokinetics 25(5): 418-429 (2010)

Pharmacokinetic/pharmacodynamic modeling of psychomotor impairment induced by oral clonazepam in healthy volunteers
, Therapeutic Drug Monitoring 31(5): 566-574 ( 2009)

Pharmacokinetic/pharmacodynamic modeling of the antiretroviral activity of the CCR5 antagonist Vicriviroc in treatment experienced HIV-infected subjects (ACTG protocol 5211)
, Journal of Acquired Immune Deficiency Syndromes 53(5): 598-605 (2010)

Pharmacokinetic/pharmacodynamic modeling to predict in vivo effectiveness of various dosing regimens of piperacillin/tazobactam and piperacillin monotherapy against gram-negative pulmonary isolates from patients managed in intensive care units in 2002
, Clinical Therapeutics 30(12): 2335-2341 (2008)

Pharmacokinetic/pharmacodynamic modelling and in vitro simulation of dynamic voriconazole-Candida interactions
, International Journal of Antimicrobial Agents 34(3): 240-245 (2009)

Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunology
, Advanced Drug Delivery Reviews 73: 127-139 (2014)

Pharmacokinetic/pharmacodynamic modelling in diabetes mellitus
, Clinical Pharmacokinetics 47(7): 417-448 (2008)

Pharmacokinetic/pharmacodynamic modelling of 2-acetyl-4(5)-tetrahydroxybutyl imidazole-induced peripheral lymphocyte sequestration through increasing lymphoid sphingosine 1-phosphate
, Xenobiotica; the Fate of Foreign Compounds in Biological Systems 40(5): 350-356 (2010)

Pharmacokinetic/pharmacodynamic modelling of robenacoxib in a feline tissue cage model of inflammation
, Journal of Veterinary Pharmacology and Therapeutics 35(1): 19-32 (2012)

Pharmacokinetic/pharmacodynamic modelling of venlafaxine: pupillary light reflex as a test system for noradrenergic effects
, Clinical Pharmacokinetics 47(11): 721-731 (2008)

Pharmacokinetic/pharmacodynamic parameters and the choice of high-dosage rifamycins
, International Journal of Tuberculosis and Lung Disease 16(9): 1186-1189 (2012 )

Pharmacokinetic/pharmacodynamic profile of posaconazole
, Clinical Pharmacokinetics 49(6): 379-396 (2010)

Pharmacokinetic/pharmacodynamic relationship of cefquinome against Pasteurella multocida in a tissue-cage model in yellow cattle
, Journal of Veterinary Pharmacology and Therapeutics 37(2): 178-185 (2014)

Pharmacokinetic/pharmacodynamic relationship of marbofloxacin against Pasteurella multocida in a tissue-cage model in yellow cattle
, Journal of Veterinary Pharmacology and Therapeutics 37(3): 222-230 (2014)

Pharmacokinetic/pharmacodynamic relationships of transdermal buprenorphine and fentanyl in experimental human pain models
, Basic and Clinical Pharmacology and Toxicology 108(4): 274-284 (2011)

Pharmacokinetic/pharmacodynamic serum and urine profile of cefditoren following single-dose and multiple twice- and thrice-daily regimens in healthy volunteers: a phase I study
, Revista Espanola de Quimioterapia 20(1): 51-60 (2007)

Pharmacokinetic/pharmacodynamic-based treatment of disseminated Mycobacterium avium
, Future Microbiology 6(4): 433-439 (2011)

Pharmacokinetically and clinician-determined adherence to an antidepressant regimen and clinical outcome in the TORDIA trial
, Journal of the American Academy of Child and Adolescent Psychiatry 50(5): 490-498 (2011)

Pharmacokinetically based estimation of patient compliance with oral anticancer chemotherapies: in silico evaluation
, Clinical Pharmacokinetics 48(6): 359-369 (2009)

Pharmacokinetically guided dose adjustment of 5-FU-A critical element toward personalized medicine
, Clinical Colorectal Cancer 13(1): 1-2 (2014)

Pharmacokinetically guided dose adjustment of 5-fluorouracil: a rational approach to improving therapeutic outcomes
, Journal of the National Cancer Institute 101(22): 1543-1552 (2009)

Pharmacokinetically guided phase 1 trial of the IGF-1 receptor antagonist RG1507 in children with recurrent or refractory solid tumors
, Clinical Cancer Research 17(3): 611-619 (2011)

Pharmacokinetically stabilized cystine knot peptides that bind alpha-v-beta-6 integrin with single-digit nanomolar affinities for detection of pancreatic cancer
, Clinical Cancer Research 18(3): 839-849 (2012)

Pharmacokinetically-guided lead optimization of nitrofuranylamide anti-tuberculosis agents
, Aaps Journal 10(1): 157-165 (2008)

Pharmacokinetics
, Pediatrics in Review 28(10): 398 (2007)

Pharmacokinetics
, Ophthalmology 116(1): 168 (2009)

Pharmacokinetics
, Biochemical Pharmacology 87(1): 93-120 (2014)

Pharmacokinetics & drug resistance of melphalan in regional chemotherapy: ILP versus ILI
, International Journal of Hyperthermia 24(3): 239-249 (2008)

Pharmacokinetics & tissue distribution of temperature-sensitive liposomal doxorubicin in tumor-bearing mice triggered with mild hyperthermia
, Biomaterials 33(18): 4608-4617 (2012)

Pharmacokinetics (PK) of mAbs
, Medecine Sciences 25(12): 1057-1062 (2009)

Pharmacokinetics 101
, Paediatrics and Child Health 16(9): 535-536 (2011)

Pharmacokinetics Alterations of Midazolam Infusion versus Bolus Administration in Mechanically Ventilated Critically Ill Patients
, Iranian Journal of Pharmaceutical Research 12(2): 483-488 (2013)

Pharmacokinetics And Pharmacodynamics Of Fenoldopam Mesylate For Blood Pressure Control In Pediatric Patients
, Bmc Anesthesiology 8: 6 (2008)

Pharmacokinetics after an intravenous single dose of the opioid ketobemidone in children
, Acta Anaesthesiologica Scandinavica 54(4): 435-441 (2010)

Pharmacokinetics after intravenous administration of flunixin meglumine in budgerigars (Melopsittacus undulatus) and Patagonian conures (Cyanoliseus patagonus)
, Journal of the American Veterinary Medical Association 242(2): 205-208 (2013)

Pharmacokinetics after intravenous, intramuscular and subcutaneous administration of moxifloxacin in sheep
, Veterinary Journal 180(3): 343-347 (2009)

Pharmacokinetics after oral and intravenous administration of a single dose of tramadol hydrochloride to Hispaniolan Amazon parrots (Amazona ventralis)
, American Journal of Veterinary Research 73(8): 1142-1147 (2012)

Pharmacokinetics analysis of sustained release hGH biodegradable implantable tablets using a mouse model of human ovarian cancer
, International Journal of Pharmaceutics 388(1-2): 175-180 (2010)

Pharmacokinetics analysis of tebipenem pivoxil in a phase II clinical trial in otolaryngological infections
, Japanese Journal of Antibiotics 62(2): 143-154 (2009)

Pharmacokinetics and 48 week efficacy of adjusted dose indinavir/ritonavir in rifampicin-treated HIV/tuberculosis-coinfected patients: a pilot study
, Aids Research and Human Retroviruses 28(10): 1170-1176 (2012)

Pharmacokinetics and 48 week efficacy of low-dose lopinavir/ritonavir in HIV-infected children
, Journal of Antimicrobial ChemoTherapy 64(5): 1080-1086 (2009)

Pharmacokinetics and 48-week efficacy of nevirapine: 400 mg versus 600 mg per day in HIV-tuberculosis coinfection receiving rifampicin
, Antiviral Therapy 13(4): 529-536 (2008)

Pharmacokinetics and 48-week safety and antiviral activity of fosamprenavir-containing regimens in HIV-infected 2- to 18-year-old children
, Pediatric Infectious Disease Journal 33(1): 50-56 (2014)

Pharmacokinetics and 48-week safety and efficacy of generic lopinavir/ritonavir in Thai HIV-infected patients
, Antiviral Therapy 18(2): 249-252 (2013)

Pharmacokinetics and ADME characterizations of antibody-drug conjugates
, Methods in Molecular Biology 1045: 117-131 (2013)

Pharmacokinetics and Biodistribution Study of 7A7 Anti-Mouse Epidermal Growth Factor Receptor Monoclonal Antibody and Its F(ab')(2) Fragment in an Immunocompetent Mouse Model
, Isrn Pharmacology 2012: 417515 (2012)

Pharmacokinetics and Excretion Studies on CDRI-85/92, an Antiulcer Proton Pump Inhibitor
, Scientia Pharmaceutica 80(1): 167-177 (2012)

Pharmacokinetics and PET imaging properties of two recombinant anti-PSMA antibody fragments in comparison to their parental antibody
, Prostate 74(7): 743-755 (2014)

Pharmacokinetics and Pharmacodynamics of Darunavir and Etravirine in HIV-1-Infected, Treatment-Experienced Patients in the Gender, Race, and Clinical Experience (GRACE) Trial
, Aids Research and Treatment 2012: 186987 (2012)

Pharmacokinetics and Reversible Biotransformation of Sulfinpyrazone and Its Metabolites in Rabbits. II. Multiple-Dose Study
, Pharmaceutical Research 3(3): 178-183 (1986)

Pharmacokinetics and Safety of ABT-578, a Sirolimus (Rapamycin) Analogue, after Single Intravenous Bolus Injection in Healthy Male Volunteers
, Clinical Drug Investigation 25(8): 491-498 (2005)

Pharmacokinetics and Safety of Duloxetine Enteric-coated Tablets in Chinese Healthy Volunteers: A Randomized, Open-label, Single- and Multiple-dose Study
, Clinical Psychopharmacology and Neuroscience 11(1): 28-33 (2013)

Pharmacokinetics and Tolerability of a New Hydroxyethyl Starch (HES) Specification [HES (130/0.4)] after Single-Dose Infusion of 6% or 10% Solutions in Healthy Volunteers
, Clinical Drug Investigation 16(2): 151-160 (1998)

Pharmacokinetics and absolute bioavailability of phenobarbital in neonates and young infants, a population pharmacokinetic modelling approach
, Fundamental and Clinical Pharmacology 28(4): 465-471 (2014)

Pharmacokinetics and absorption of paromomycin and gentamicin from topical creams used to treat cutaneous leishmaniasis
, Antimicrobial Agents and ChemoTherapy 57(10): 4809-4815 (2013)

Pharmacokinetics and absorption of posaconazole oral suspension under various gastric conditions in healthy volunteers
, Antimicrobial Agents and ChemoTherapy 53(3): 958-966 (2009)

Pharmacokinetics and absorption of the anticancer agents dasatinib and GDC-0941 under various gastric conditions in dogs--reversing the effect of elevated gastric pH with betaine HCl
, Molecular Pharmaceutics 10(11): 4024-4031 (2013)

Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW Trial
, Antiviral Therapy 15(8): 1115-1124 (2010)

Pharmacokinetics and administration method of gentamicin in a patient on haemodialysis
, Scandinavian Journal of Infectious Diseases 44(8): 630-634 (2012)

Pharmacokinetics and administration of drugs in patients with hepatic failure
, Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl. 8): 53-57 (2007)

Pharmacokinetics and aging
, Soins. Gerontologie 2013(100): 43-44 (2013)

Pharmacokinetics and analgesic effect of ketorolac floating delivery system
, Drug Delivery 22(3): 320-327 (2015)

Pharmacokinetics and analgesic effects of intravenous propacetamol vs rectal paracetamol in children after major craniofacial surgery
, Paediatric Anaesthesia 18(7): 582-592 (2008)

Pharmacokinetics and anthelmintic efficacy of topical eprinomectin in goats prevented from grooming
, Parasitology Research 113(11): 4039-4044 (2014)

Pharmacokinetics and anti-hypertensive effect of metoprolol tartrate rectal delivery system
, Drug Delivery 23(1): 69-78 (2016)

Pharmacokinetics and anti-inflammatory pharmacodynamics of prednisolone in cynomolgus monkey
, Xenobiotica; the Fate of Foreign Compounds in Biological Systems 39(11): 862-870 (2009)

Pharmacokinetics and antibody responses to the CD3 antibody otelixizumab used in the treatment of type 1 diabetes
, Journal of Clinical Pharmacology 50(11): 1238-1248 (2010)

Pharmacokinetics and antihypertensive effects of candesartan cilexetil in patients undergoing haemodialysis: an open-label, single-centre study
, Clinical Drug Investigation 29(11): 713-719 (2009)

Pharmacokinetics and antimicrobial dosing adjustment in critically ill patients during continuous renal replacement therapy
, Clinical Nephrology 67(5): 267-284 (2007)

Pharmacokinetics and antineoplastic activity of galectin-1-targeting OTX008 in combination with sunitinib
, Cancer ChemoTherapy and Pharmacology 72(4): 879-887 (2013)

Pharmacokinetics and antinociceptive effects of oral tramadol hydrochloride administration in Greyhounds
, American Journal of Veterinary Research 72(2): 256-262 (2011)

Pharmacokinetics and antitumor effects of the drug containing TNF-α in nanoparticles
, Bulletin of Experimental Biology and Medicine 149(3): 320-323 (2010)

Pharmacokinetics and antitumor efficacy of XMT-1001, a novel, polymeric topoisomerase I inhibitor, in mice bearing HT-29 human colon carcinoma xenografts
, Clinical Cancer Research 18(9): 2591-2602 (2012)

Pharmacokinetics and antitumor efficacy of chemoembolization using 40 µm irinotecan-loaded microspheres in a rabbit liver tumor model
, Journal of Vascular and Interventional Radiology 25(7): 1037-1044.E2 (2014)

Pharmacokinetics and antitumor efficacy of paclitaxel-cyclodextrin complexes loaded in mucus-penetrating nanoparticles for oral administration
, Nanomedicine 9(14): 2109-2121 (2014)

Pharmacokinetics and antiviral activity of PHX1766, a novel HCV protease inhibitor, using an accelerated Phase I study design
, Antiviral Therapy 17(2): 365-375 (2012)

Pharmacokinetics and applications of magnetic nanoparticles
, Current Drug Metabolism 14(8): 872-878 (2013)

Pharmacokinetics and atherosclerotic lesions targeting effects of tanshinone IIA discoidal and spherical biomimetic high density lipoproteins
, Biomaterials 34(1): 306-319 (2013)

Pharmacokinetics and behavioral effects of an extended-release, liposome-encapsulated preparation of oxymorphone in rhesus macaques
, Journal of Pharmacology and Experimental Therapeutics 330(1): 135-141 (2009)

Pharmacokinetics and behavioral effects of liposomal hydromorphone suitable for perioperative use in rhesus macaques
, Psychopharmacology 216(4): 511-523 (2011)

Pharmacokinetics and behavioral effects of oxymorphone after intravenous and subcutaneous administration to healthy dogs
, Journal of Veterinary Pharmacology and Therapeutics 31(6): 580-583 (2008)

Pharmacokinetics and biliary excretion of mitoxantrone in rats
, Journal of Pharmaceutical Sciences 99(5): 2502-2510 (2010)

Pharmacokinetics and bioactivity of glial cell line-derived factor (GDNF) and neurturin (NTN) infused into the rat brain
, Neuropharmacology 58(7): 1114-1121 (2010)

Pharmacokinetics and bioavailabilities of geniposide in Beagle dogs after oral administration Xingnaojing
, Zhongguo Zhong Yao Za Zhi 37(16): 2461-2464 (2012)

Pharmacokinetics and bioavailability comparison of generic and branded citalopram 20 mg tablets: an open-label, randomized-sequence, two-period crossover study in healthy Chinese CYP2C19 extensive metabolizers
, Clinical Drug Investigation 33(1): 1-9 (2013)

Pharmacokinetics and bioavailability of Puerarin self-microemulsion in Beagle dogs
, Zhong Yao Cai 34(5): 750-753 (2011)

Pharmacokinetics and bioavailability of a long-acting formulation of cephalexin after intramuscular administration to cats
, Research in Veterinary Science 91(1): 129-131 (2011)

Pharmacokinetics and bioavailability of an integrase and novel pharmacoenhancer-containing single-tablet fixed-dose combination regimen for the treatment of HIV
, Journal of Acquired Immune Deficiency Syndromes 55(3): 323-329 (2010)

Pharmacokinetics and bioavailability of cantharidin in beagle dogs
, Zhongguo Zhong Yao Za Zhi 34(16): 2088-2091 (2009)

Pharmacokinetics and bioavailability of cefquinome in crossbred wild boars
, Journal of Veterinary Pharmacology and Therapeutics 35(6): 611-614 (2012)

Pharmacokinetics and bioavailability of cefquinome in healthy ducks
, American Journal of Veterinary Research 72(1): 122-126 (2011)

Pharmacokinetics and bioavailability of cefquinome in rabbits following intravenous and intramuscular administration
, Journal of Veterinary Pharmacology and Therapeutics 34(6): 618-620 (2011)

Pharmacokinetics and bioavailability of cimicifugosides after oral administration of Cimicifuga foetida L. extract to rats
, Journal of Ethnopharmacology 143(1): 249-255 (2012)

Pharmacokinetics and bioavailability of cinnamic acid after oral administration of Ramulus Cinnamomi in rats
, European Journal of Drug Metabolism and Pharmacokinetics 34(1): 51-56 (2009)

Pharmacokinetics and bioavailability of gentiopicroside from decoctions of Gentianae and Longdan Xiegan Tang after oral administration in rats--comparison with gentiopicroside alone
, Journal of Pharmaceutical and Biomedical Analysis 44(5): 1113-1117 (2007)

Pharmacokinetics and bioavailability of ginsenoside Rg1 in rats
, Zhong Yao Cai 36(7): 1121-1123 (2013)

Pharmacokinetics and bioavailability of metformin in horses
, American Journal of Veterinary Research 70(5): 665-668 (2009)

Pharmacokinetics and bioavailability of moxifloxacin in buffalo calves
, Research in Veterinary Science 89(1): 108-112 (2010)

Pharmacokinetics and bioavailability of moxifloxacin in calves following different routes of administrations
, ChemoTherapy 56(1): 26-31 (2010)

Pharmacokinetics and bioavailability of oxycodone and acetaminophen following single-dose administration of MNK-795, a dual-layer biphasic IR/ER combination formulation, under fed and fasted conditions
, Drug Design Development and Therapy 8: 1125-1134 (2014)

Pharmacokinetics and bioavailability of plant lignan 7-hydroxymatairesinol and effects on serum enterolactone and clinical symptoms in postmenopausal women: a single-blinded, parallel, dose-comparison study
, Journal of the American College of Nutrition 32(6): 428-435 (2013)

Pharmacokinetics and bioavailability of single dose ibuprofen and pseudoephedrine alone or in combination: a randomized three-period, cross-over trial in healthy Indian volunteers
, Frontiers in Pharmacology 5: 98 (2014)

Pharmacokinetics and bioavailability of sustained-release tablets of matrine in dogs
, Zhong Yao Cai 33(8): 1293-1296 (2010)

Pharmacokinetics and bioavailability of valnemulin in Muscovy ducks (Cairina moschata)
, British Poultry Science 53(3): 374-378 (2012)

Pharmacokinetics and bioavailability of valnemulin in broiler chickens
, Journal of Veterinary Pharmacology and Therapeutics 34(3): 247-251 (2011)

Pharmacokinetics and bioavailability study of polydatin in rat plasma by using a LC-MS/MS method
, Pakistan Journal of Pharmaceutical Sciences 27(6): 1931-1937 (2014)

Pharmacokinetics and biodegradation mechanisms of a versatile carboxymethyl derivative of chitosan in rats: in vivo and in vitro evaluation
, Biomacromolecules 11(6): 1527-1533 (2010)

Pharmacokinetics and biodistribution of 99mTc N-MPO in healthy human volunteers
, Clinical Nuclear Medicine 39(1): E14 (2014)

Pharmacokinetics and biodistribution of Erufosine in nude mice--implications for combination with radiotherapy
, Radiation Oncology 4: 46 (2009)

Pharmacokinetics and biodistribution of N-isopropylacrylamide copolymers for the design of pH-sensitive liposomes
, Biomaterials 30(13): 2598-2605 (2009)

Pharmacokinetics and biodistribution of Photolon (Fotolon) in intact and tumor-bearing rats
, Photodiagnosis and Photodynamic Therapy 6(2): 97-104 (2009)

Pharmacokinetics and biodistribution of a human monoclonal antibody to oxidized LDL in cynomolgus monkey using PET imaging
, Plos one 7(9): E45116 (2012)

Pharmacokinetics and biodistribution of amphotericin B in rats following oral administration in a novel lipid-based formulation
, Journal of Antimicrobial ChemoTherapy 64(1): 101-108 (2009)

Pharmacokinetics and biodistribution of human serum albumin-TIMP-2 fusion protein using near-infrared optical imaging
, Journal of Pharmacy and Pharmaceutical Sciences 14(3): 368-377 (2011)

Pharmacokinetics and biodistribution of itraconazole in rats and mice following intravenous administration in a novel liposome formulation
, Drug Delivery 17(4): 223-230 (2010)

Pharmacokinetics and biodistribution of lonidamine/paclitaxel loaded, EGFR-targeted nanoparticles in an orthotopic animal model of multi-drug resistant breast cancer
, Nanomedicine 7(4): 435-444 (2011)

Pharmacokinetics and biodistribution of nanoparticles
, Molecular Pharmaceutics 5(4): 496-504 (2008)

Pharmacokinetics and biodistribution of near-infrared fluorescence polymeric nanoparticles
, Nanotechnology 20(16): 165101 (2009)

Pharmacokinetics and biodistribution of paclitaxel loaded in pegylated solid lipid nanoparticles after intravenous administration
, Archives of Pharmacal Research 34(2): 331-337 (2011)

Pharmacokinetics and biodistribution of paclitaxel-loaded pluronic P105/L101 mixed polymeric micelles
, Yakugaku Zasshi 128(6): 941-950 (2008)

Pharmacokinetics and biodistribution of the cyclin-dependent kinase inhibitor -CR8- in mice
, Bmc Pharmacology and Toxicology 14: 50 (2013)

Pharmacokinetics and biodistribution of zinc-enriched yeast in rats
, Thescientificworldjournal 2014: 217142 (2014)

Pharmacokinetics and bioequivalence evaluation of cyclobenzaprine tablets
, Biomed Research International 2013: 281392 (2013)

Pharmacokinetics and bioequivalence evaluation of gliclazide/metformin combination tablet and equivalent doses of gliclazide and metformin in healthy Korean subjects
, International Journal of Clinical Pharmacology and Therapeutics 47(12): 770-779 (2009)

Pharmacokinetics and bioequivalence evaluation of two different atorvastatin calcium 10-mg tablets: A single-dose, randomized-sequence, open-label, two-period crossover study in healthy fasted Chinese adult males
, Clinical Therapeutics 32(7): 1396-1407 (2010)

Pharmacokinetics and bioequivalence evaluation of two fixed-dose tablet formulations of dihydroartemisinin and piperaquine in Vietnamese subjects
, Antimicrobial Agents and ChemoTherapy 53(2): 828-831 (2009)

Pharmacokinetics and bioequivalence evaluation of two formulations of 10-mg amlodipine besylate: an open-label, single-dose, randomized, two-way crossover study in healthy Chinese male volunteers
, Clinical Therapeutics 31(4): 777-783 (2009)

Pharmacokinetics and bioequivalence evaluation of two losartan potassium 50-mg tablets: A single-dose, randomized-sequence, open-label, two-way crossover study in healthy Chinese male volunteers
, Clinical Therapeutics 32(7): 1387-1395 (2010)

Pharmacokinetics and bioequivalence of 20 mg omeprazole capsule in 24 healthy Korean male volunteers
, International Journal of Clinical Pharmacology and Therapeutics 47(1): 23-29 (2009)

Pharmacokinetics and bioequivalence of atorvastatin calcium tablets in healthy male Chinese volunteers
, Zhonghua Xin Xue Guan Bing Za Zhi 40(3): 243-247 (2012)

Pharmacokinetics and bioequivalence of domestic trimetazidine formulations
, Zhonghua Xin Xue Guan Bing Za Zhi 40(12): 1041-1044 (2012)

Pharmacokinetics and bioequivalence of sildenafil granules and sildenafil tablets in Korean healthy volunteers
, International Journal of Clinical Pharmacology and Therapeutics 52(6): 530-536 (2014)

Pharmacokinetics and bioequivalence of single dose and multiple doses of immediate- and extended-release formulations of dexibuprofen in healthy Chinese subjects
, International Journal of Clinical Pharmacology and Therapeutics 49(3): 237-246 (2011)

Pharmacokinetics and bioequivalence of two formulations of rebamipide 100-mg tablets: a randomized, single-dose, two-period, two-sequence crossover study in healthy Korean male volunteers
, Clinical Therapeutics 31(11): 2712-2721 (2009)

Pharmacokinetics and bioequivalence studies of cefteram pivoxil in healthy Chinese volunteers
, European Journal of Drug Metabolism and Pharmacokinetics 34(3-4): 157-162 (2009)

Pharmacokinetics and bioequivalence studies of galantamine hydrobromide dispersible tablet in healthy male Chinese volunteers
, Drug Development and Industrial Pharmacy 33(3): 335-340 (2007)

Pharmacokinetics and bioequivalence study of irbesartan tablets after a single oral dose of 300 mg in healthy Thai volunteers
, International Journal of Clinical Pharmacology and Therapeutics 52(5): 431-436 (2014)

Pharmacokinetics and bioequivalence study of three oral formulations of ambroxol 30 mg: a randomized, three-period crossover comparison in healthy volunteers
, International Journal of Clinical Pharmacology and Therapeutics 52(10): 920-926 (2014)

Pharmacokinetics and bioequivalence study of three oral formulations of valsartan 160 mg: a single-dose, randomized, open-label, three-period crossover comparison in healthy Indian male volunteers
, Clinical Therapeutics 32(3): 588-596 (2010)

Pharmacokinetics and biological effect of the recombinant human bone morphogenetic protein-7
, Medicinski Arhiv 61(1): 3-6 (2007)

Pharmacokinetics and biotransformation of tea polyphenols
, Current Drug Metabolism 15(1): 30-36 (2014)

Pharmacokinetics and blood-brain barrier penetration of (+)-catechin and (-)-epicatechin in rats by microdialysis sampling coupled to high-performance liquid chromatography with chemiluminescence detection
, Journal of Agricultural and Food Chemistry 60(37): 9377-9383 (2012)

Pharmacokinetics and bone formation by BMP-2 entrapped in polyethylenimine-coated albumin nanoparticles
, Biomaterials 30(28): 5143-5155 (2009)

Pharmacokinetics and bone resorption evaluation of a novel Cathepsin K inhibitor (VEL-0230) in healthy adult horses
, Journal of Veterinary Pharmacology and Therapeutics 37(6): 556-564 (2014)

Pharmacokinetics and bone tissue concentrations of lincomycin following intravenous and intramuscular administrations to cats
, Journal of Veterinary Pharmacology and Therapeutics 35(6): 534-540 (2012)

Pharmacokinetics and brain dispositions of tacrine and its major bioactive monohydroxylated metabolites in rats
, Journal of Pharmaceutical and Biomedical Analysis 61: 57-63 (2012)

Pharmacokinetics and brain distribution differences of baicalin in rat underlying the effect of Panax notoginsenosides after intravenous administration
, Chinese Journal of Natural Medicines 12(8): 632-640 (2014)

Pharmacokinetics and brain distribution of ginsenosides after administration of sailuotong
, Zhongguo Zhong Yao Za Zhi 39(2): 316-321 (2014)

Pharmacokinetics and brain penetration of LF-3-88, (2-[5-[5-(2(S)-azetidinylmethoxyl)-3-pyridyl]-3-isoxazolyl]ethanol), a selective α4β2-nAChR partial agonist and promising antidepressant
, Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 912: 38-42 (2013)

Pharmacokinetics and brain penetration of casopitant, a potent and selective neurokinin-1 receptor antagonist, in the ferret
, Drug Metabolism and Disposition: the Biological Fate of Chemicals 36(9): 1846-1852 (2008)

Pharmacokinetics and brain uptake of a genetically engineered bifunctional fusion antibody targeting the mouse transferrin receptor
, Molecular Pharmaceutics 7(1): 237-244 (2010)

Pharmacokinetics and brain uptake of an IgG-TNF decoy receptor fusion protein following intravenous, intraperitoneal, and subcutaneous administration in mice
, Molecular Pharmaceutics 10(4): 1425-1431 (2013)

Pharmacokinetics and brain uptake of diazepam after intravenous and intranasal administration in rats and rabbits
, International Journal of Pharmaceutics 364(1): 27-35 (2008)

Pharmacokinetics and buccal mucosal concentrations of a 15 milligram per kilogram of body weight total dose of liposomal amphotericin B administered as a single dose (15 mg/kg), weekly dose (7.5 mg/kg), or daily dose (1 mg/kg) in peripheral stem cell transplant patients
, Antimicrobial Agents and ChemoTherapy 53(9): 3664-3674 (2009)

Pharmacokinetics and central nervous system effects of the novel dopamine D2 receptor antagonist JNJ-37822681
, Journal of Psychopharmacology 26(8): 1119-1127 (2012)

Pharmacokinetics and central nervous system effects of the novel dopamine D3 receptor antagonist GSK598809 and intravenous alcohol infusion at pseudo-steady state
, Journal of Psychopharmacology 26(2): 303-314 (2012)

Pharmacokinetics and central nervous system effects of the novel dual NK1 /NK3 receptor antagonist GSK1144814 in alcohol-intoxicated volunteers
, British Journal of Clinical Pharmacology 75(5): 1328-1339 (2013)

Pharmacokinetics and clinical application of intravenous valproate in Thai epileptic children
, Brain and Development 33(3): 189-194 (2011)

Pharmacokinetics and clinical efficacy of cefuroxime in the newborn period
, Proceedings of the Royal Society of Medicine 70(Suppl 9): 179-182 (1977)

Pharmacokinetics and clinical efficacy of delmopinol in an open rinse time study in healthy volunteers
, American Journal of Dentistry 24(6): 383-388 (2011)

Pharmacokinetics and clinical efficacy of midazolam in children with severe malaria and convulsions
, British Journal of Clinical Pharmacology 66(4): 529-538 (2008)

Pharmacokinetics and clinical efficacy of phenobarbital in asphyxiated newborns treated with hypothermia: a thermopharmacological approach
, Clinical Pharmacokinetics 51(10): 671-679 (2012)

Pharmacokinetics and clinical predictors of surfactant redosing in respiratory distress syndrome
, Intensive Care Medicine 37(3): 510-517 (2011)

Pharmacokinetics and clinical toxicity of prilocaine and ropivacaine following combined drug administration in brachial plexus anesthesia
, International Journal of Clinical Pharmacology and Therapeutics 47(12): 733-743 (2009)

Pharmacokinetics and clinical use of incretin-based therapies in patients with chronic kidney disease and type 2 diabetes
, Clinical Pharmacokinetics 54(1): 1-21 (2015)

Pharmacokinetics and comparative bioavailability of two metformin formulations after single-dose administration in healthy subjects
, Clinical Drug Investigation 23(11): 743-749 (2003)

Pharmacokinetics and concentration-effect relationship of adalimumab in rheumatoid arthritis
, British Journal of Clinical Pharmacology 79(2): 286-297 (2015)

Pharmacokinetics and correlation analysis of cilostazol in healthy Korean subjects
, International Journal of Clinical Pharmacology and Therapeutics 50(5): 345-348 (2012)

Pharmacokinetics and cytotoxic effect of selenium compounds in rodent cancer xenograft model for therapy experiment
, Journal of Gynecologic Oncology 24(1): 96-97 (2013)

Pharmacokinetics and cytotoxicity of epirubicin (epi) in drug-resistant human hepatoma-cells (hb8065)
, International Journal of Oncology 4(6): 1229-1235 (1994)

Pharmacokinetics and delta1-cortienic acid excretion after intravenous administration of prednisolone and loteprednol etabonate in rats
, Die Pharmazie 65(6): 412-416 (2010)

Pharmacokinetics and derivation of an anticancer dosing regimen for PAC-1, a preferential small molecule activator of procaspase-3, in healthy dogs
, Investigational new Drugs 29(5): 901-911 (2011)

Pharmacokinetics and dialysate levels of daptomycin given intravenously in a peritoneal dialysis patient
, Scandinavian Journal of Infectious Diseases 41(2): 155-157 (2009)

Pharmacokinetics and disposition of CS-8958, a long-acting prodrug of the novel neuraminidase inhibitor laninamivir in rats
, Xenobiotica; the Fate of Foreign Compounds in Biological Systems 40(3): 207-216 (2010)

Pharmacokinetics and disposition of a localized lymphatic polymeric hyaluronan conjugate of cisplatin in rodents
, Journal of Pharmaceutical Sciences 99(6): 2664-2671 (2010)

Pharmacokinetics and disposition of dalcetrapib in rats and monkeys
, Xenobiotica; the Fate of Foreign Compounds in Biological Systems 44(12): 1117-1126 (2014)

Pharmacokinetics and disposition of nanomedicine using biodegradable PEG/PCL polymers as drug carriers
, Current Drug Metabolism 13(4): 338-353 (2012)

Pharmacokinetics and disposition of rilpivirine (TMC278) nanosuspension as a long-acting injectable antiretroviral formulation
, Antimicrobial Agents and ChemoTherapy 54(5): 2042-2050 (2010)

Pharmacokinetics and disposition of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) nanoparticles
, Current Drug Metabolism 11(10): 859-869 (2010)

Pharmacokinetics and disposition of various drug loaded liposomes
, Current Drug Metabolism 13(4): 372-395 (2012)

Pharmacokinetics and disposition study of calf thymus DNA in rats by applying 3H-labeling method
, Journal of Pharmaceutical and Biomedical Analysis 64-65: 35-39 (2012)

Pharmacokinetics and distribution of SN 28049, a novel DNA binding anticancer agent, in mice
, Cancer ChemoTherapy and Pharmacology 65(6): 1145-1152 (2010)

Pharmacokinetics and distribution of ceftazidime to milk after intravenous and intramuscular administration to lactating female dromedary camels (Camelus dromedarius)
, Journal of the American Veterinary Medical Association 243(3): 424-429 (2013)

Pharmacokinetics and distribution of fluvoxamine to the brain in rats under oxidative stress
, Free Radical Research 46(7): 831-841 (2012)

Pharmacokinetics and distribution of linezolid in cerebrospinal fluid in children and adolescents
, Pediatric Infectious Disease Journal 29(9): 827-830 (2010)

Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction
, European Journal of Clinical Pharmacology 64(12): 1147-1161 (2008)

Pharmacokinetics and dosage adjustment in patients with renal dysfunction
, European Journal of Clinical Pharmacology 65(8): 757-773 (2009)

Pharmacokinetics and dosage individualization of ganciclovir and valganciclovir in an infant with nephrotic syndrome associated with cytomegalovirus infection
, Journal of Antimicrobial ChemoTherapy 69(4): 1150-1151 (2014)

Pharmacokinetics and dosage regimen of ciprofloxacin following single intramuscular administration in Teddy goats
, Pakistan Journal of Pharmaceutical Sciences 24(1): 69-74 (2011)

Pharmacokinetics and dose escalation of the heat shock protein inhibitor 17-allyamino-17-demethoxygeldanamycin in combination with bortezomib in relapsed or refractory acute myeloid leukemia
, Leukemia and Lymphoma 54(9): 1996-2002 (2013)

Pharmacokinetics and dose proportionality of three Tramadol Contramid OAD tablet strengths
, Biopharmaceutics and Drug Disposition 28(6): 323-330 (2007)

Pharmacokinetics and dose recommendations of Niaspan® in chronic kidney disease and dialysis patients
, Nephrology Dialysis Transplantation 26(1): 276-282 (2011)

Pharmacokinetics and dose requirements of factor VIII over the age range 3-74 years: a population analysis based on 50 patients with long-term prophylactic treatment for haemophilia A
, European Journal of Clinical Pharmacology 65(10): 989-998 (2009)

Pharmacokinetics and dose response of anti-TB drugs in rat infection model of tuberculosis
, Tuberculosis 94(3): 282-286 (2014)

Pharmacokinetics and dose selection of a novel, long-acting transdermal fentanyl solution in healthy laboratory Beagles
, Journal of Veterinary Pharmacology and Therapeutics 35(Suppl. 2): 21-26 (2012)

Pharmacokinetics and dose-range finding toxicity of a novel anti-HIV active integrase inhibitor
, Antiviral Research 108: 25-29 (2014)

Pharmacokinetics and dosimetry of (111)In/(188)Re-labeled PEGylated liposomal drugs in two colon carcinoma-bearing mouse models
, Cancer BioTherapy and Radiopharmaceuticals 26(3): 373-380 (2011)

Pharmacokinetics and dosimetry of 188 Re-pharmaceuticals
, Advanced Drug Delivery Reviews 60(12): 1389-1401 (2008)

Pharmacokinetics and drug dosing in obese children
, Journal of Pediatric Pharmacology and Therapeutics 15(2): 94-109 (2010)

Pharmacokinetics and drug interactions of newer anti -leprosy drugs
, Indian Journal of Dermatology Venereology and Leprology 63(3): 148-152 (1997)

Pharmacokinetics and drug metabolism in the elderly
, Drug Metabolism Reviews 41(2): 67-76 (2009)

Pharmacokinetics and drug-drug interactions of antiretrovirals: an update
, Antiviral Research 85(1): 176-189 (2010)

Pharmacokinetics and effect of food after oral administration of prolonged-release tablets of ropinirole hydrochloride in Japanese patients with Parkinson's disease
, Journal of Clinical Pharmacy and Therapeutics 37(5): 571-577 (2012)

Pharmacokinetics and effects of cetirizine in horses with insect bite hypersensitivity
, Veterinary Journal 187(3): 347-351 (2011)

Pharmacokinetics and effects on serum cholinesterase activities of organophosphorus pesticides acephate and chlorpyrifos in chimeric mice transplanted with human hepatocytes
, Regulatory Toxicology and Pharmacology 70(2): 468-473 (2014)

Pharmacokinetics and efficacy of Bioerodible Dexamethasone implant in Concanavalin A-induced uveitic cataract rabbit model
, Pharmaceutical Research 31(11): 3179-3190 (2014)

Pharmacokinetics and efficacy of PEGylated liposomal doxorubicin in an intracranial model of breast cancer
, Plos one 8(5): E61359 (2013)

Pharmacokinetics and efficacy of a biweekly dosage formulation of exenatide in Zucker diabetic fatty (ZDF) rats
, Pharmaceutical Research 26(11): 2504-2512 (2009)

Pharmacokinetics and efficacy of a direct switch from conventional depot to risperidone long-acting injection in Chinese patients with schizophrenic and schizoaffective disorders
, Psychiatry and Clinical Neurosciences 63(4): 440-448 (2009)

Pharmacokinetics and efficacy of ceftazidime in experimental Haemophilus influenzae b meningitis
, Journal of Antimicrobial ChemoTherapy 8 Suppl B: 339-343 (1981)

Pharmacokinetics and efficacy of darunavir/ritonavir once daily in virologically suppressed, treatment-experienced HIV-infected children
, HIV Medicine 15(8): 511-512 (2014)

Pharmacokinetics and efficacy of fluvoxamine and amitriptyline in depression
, Journal of Pharmacological Sciences 110(1): 98-104 (2009)

Pharmacokinetics and efficacy of intravenous or intramuscular hepatitis B immunoglobulins in prophylaxis of hepatitis B after liver transplantation
, Minerva Medica 101(6): 373-383 (2010)

Pharmacokinetics and efficacy of liposomal polymyxin B in a murine pneumonia model
, International Journal of Antimicrobial Agents 42(6): 559-564 (2013)

Pharmacokinetics and efficacy of low-dose ketoprofen in postoperative dental pain
, Clinical Drug Investigation 15(4): 279-284 (1998)

Pharmacokinetics and efficacy of ropivacaine in Chinese patients following intra-articular administration
, International Journal of Clinical Pharmacology and Therapeutics 51(5): 393-400 (2013)

Pharmacokinetics and efficacy of teicoplanin against intramammary infections in sheep
, Veterinary Record 165(1): 19-22 (2009)

Pharmacokinetics and efficacy of the spleen tyrosine kinase inhibitor r406 after ocular delivery for retinoblastoma
, Pharmaceutical Research 31(11): 3060-3072 (2014)

Pharmacokinetics and efficacy of topically applied nonsteroidal anti-inflammatory drugs in retinochoroidal tissues in rabbits
, Plos one 9(5): E96481 (2014)

Pharmacokinetics and efficiency of brain targeting of ginsenosides Rg1 and Rb1 given as Nao-Qing microemulsion
, Drug Development and Industrial Pharmacy 41(2): 224-231 (2015)

Pharmacokinetics and elimination efficiency of linezolid during dialysis
, Renal Failure 35(3): 418-420 (2013)

Pharmacokinetics and elimination of quetiapine, venlafaxine, and trazodone during pregnancy and postpartum
, Journal of Clinical Psychopharmacology 27(6): 720-722 (2007)

Pharmacokinetics and elucidation of the rates and routes of N-glucuronidation of PF-592379, an oral dopamine 3 agonist in rat, dog, and human
, Xenobiotica; the Fate of Foreign Compounds in Biological Systems 40(11): 730-742 (2010)

Pharmacokinetics and enhanced PKR response in patients with chronic hepatitis C treated with pegylated interferon alpha-2b and ribavirin
, Journal of Viral Hepatitis 14(6): 396-403 (2007)

Pharmacokinetics and enhanced bioavailability of candidate cancer preventative agent, SR13668 in dogs and monkeys
, Cancer ChemoTherapy and Pharmacology 65(6): 1109-1116 (2010)

Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles
, International Journal of Nanomedicine 5: 13-23 (2010)

Pharmacokinetics and ex vivo antimalarial activity of artesunate-azithromycin in healthy volunteers
, Antimicrobial Agents and ChemoTherapy 55(9): 4412-4415 (2011)

Pharmacokinetics and ex vivo pharmacodynamic antimalarial activity of dihydroartemisinin-piperaquine in patients with uncomplicated falciparum malaria in Vietnam
, Antimicrobial Agents and ChemoTherapy 53(8): 3534-3537 (2009)

Pharmacokinetics and ex vivo pharmacodynamics of cefquinome in porcine serum and tissue cage fluids
, Veterinary Journal 199(3): 399-405 (2014)

Pharmacokinetics and ex-vivo pharmacodynamics of cefquinome against Klebsiella pneumonia in healthy dogs
, Journal of Veterinary Pharmacology and Therapeutics 37(4): 367-373 (2014)

Pharmacokinetics and excretion of (14)C-lenvatinib in patients with advanced solid tumors or lymphomas
, Investigational new Drugs 33(1): 233-240 (2015)

Pharmacokinetics and excretion study of sophoricoside and its metabolite in rats by liquid chromatography tandem mass spectrometry
, Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 945-946: 154-162 (2014)

Pharmacokinetics and exposure-effect relationships of capecitabine in elderly patients with breast or colorectal cancer
, Cancer ChemoTherapy and Pharmacology 73(6): 1285-1293 (2014)

Pharmacokinetics and first-pass effects of epsilon-acetamidocaproic acid after administration of zinc acexamate in rats
, Xenobiotica; the Fate of Foreign Compounds in Biological Systems 40(7): 485-498 (2010)

Pharmacokinetics and first-pass effects of liquiritigenin in rats: low bioavailability is primarily due to extensive gastrointestinal first-pass effect
, Xenobiotica; the Fate of Foreign Compounds in Biological Systems 39(6): 465-475 (2009)

Pharmacokinetics and first-pass elimination of metoprolol in rats: contribution of intestinal first-pass extraction to low bioavailability of metoprolol
, Xenobiotica; the Fate of Foreign Compounds in Biological Systems 41(3): 243-251 (2011)

Pharmacokinetics and first-pass metabolism of astaxanthin in rats
, British Journal of Nutrition 105(2): 220-227 (2011)

Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF
, Reproductive Biomedicine Online 22(Suppl. 1): S23 (2011)

Pharmacokinetics and food interaction of a novel prodrug of tenofovir, tenofovir dipivoxil fumarate, in healthy volunteers
, Journal of Clinical Pharmacy and Therapeutics 38(2): 136-140 (2013)

Pharmacokinetics and hepatic uptake of gliquidone affected by Huangqi injection
, European Journal of Drug Metabolism and Pharmacokinetics 39(4): 255-261 (2014)

Pharmacokinetics and imaging of 212Pb-TCMC-trastuzumab after intraperitoneal administration in ovarian cancer patients
, Cancer BioTherapy and Radiopharmaceuticals 29(1): 12-17 (2014)

Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment
, Investigative Radiology 46(9): 556-566 (2011)

Pharmacokinetics and immunodynamics of basiliximab in pediatric renal transplant recipients on mycophenolate mofetil comedication
, Transplantation 86(9): 1234-1240 (2008)

Pharmacokinetics and immunoglobulin response of subcutaneous and intravenous atacicept in patients with systemic lupus erythematosus
, Journal of Pharmaceutical Sciences 99(1): 524-538 (2010)

Pharmacokinetics and immunologic consequences of repeated administrations of purified heterologous and homologous butyrylcholinesterase in mice
, Life Sciences 85(17-18): 657-661 (2009)

Pharmacokinetics and impaired organic functions
, Bulletin du Cancer 98(11): 1347-1354 (2011)

Pharmacokinetics and improved bioavailability of toltrazuril after oral administration to rabbits
, Journal of Veterinary Pharmacology and Therapeutics 33(5): 503-506 (2010)

Pharmacokinetics and in vivo antistaphylococcal efficacy of TXY541, a 1-methylpiperidine-4-carboxamide prodrug of PC190723
, Biochemical Pharmacology 86(12): 1699-1707 (2013)

Pharmacokinetics and in vivo biodistribution of optimized PLGA nanoparticulate drug delivery system for controlled release of emtricitabine
, Drug Delivery 21(8): 627-635 (2014)

Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development
, Journal of Pharmaceutical Sciences 97(11): 4696-4740 (2008)

Pharmacokinetics and in vivo fate of drug loaded chitosan nanoparticles
, Current Drug Metabolism 13(4): 364-371 (2012)

Pharmacokinetics and in vivo potency of soluble epoxide hydrolase inhibitors in cynomolgus monkeys
, British Journal of Pharmacology 165(5): 1401-1412 (2012)

Pharmacokinetics and interactions of raltegravir
, Enfermedades Infecciosas y Microbiologia Clinica 26(Suppl. 12): 23-28 (2008)

Pharmacokinetics and interspecies allometric scaling of ST-246, an oral antiviral therapeutic for treatment of orthopoxvirus infection
, Plos one 8(4): E61514 (2013)

Pharmacokinetics and intramuscular bioavailability of a single dose of butorphanol in Asian elephants (Elephas maximus)
, Journal of Zoo and Wildlife Medicine 41(3): 418-425 (2010)

Pharmacokinetics and intramuscular bioavailability of difloxacin in dromedary camels (Camelus dromedarius)
, Veterinary Journal 179(2): 282-286 (2009)

Pharmacokinetics and its relation to toxicity of pegylated-liposomal doxorubicin in Chinese patients with breast tumours
, Journal of Clinical Pharmacy and Therapeutics 35(5): 593-601 (2010)

Pharmacokinetics and linear exposure of AFRESA compared with the subcutaneous injection of regular human insulin
, Diabetes Obesity and Metabolism 11(7): 715-720 (2009)

Pharmacokinetics and liver distribution study of unbound curdione and curcumol in rats by microdialysis coupled with rapid resolution liquid chromatography (RRLC) and tandem mass spectrometry
, Journal of Pharmaceutical and Biomedical Analysis 95: 146-150 (2014)

Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia
, Critical Care 13(6): R200 (2009)

Pharmacokinetics and lung distribution of a humanized anti-RAGE antibody in wild-type and RAGE-/- mice
, Mabs 2(5): 571-575 (2010)

Pharmacokinetics and magnetic resonance imaging of biodegradable macromolecular blood-pool contrast agent PG-Gd in non-human primates: a pilot study
, Contrast Media and Molecular Imaging 6(4): 289-297 (2011)

Pharmacokinetics and mechanism of intestinal absorption of JBP485 in rats
, Drug Metabolism and Pharmacokinetics 25(5): 500-507 (2010)

Pharmacokinetics and metabolic disposition of exogenous phosphocreatine in rats
, Yao Xue Xue Bao 46(1): 75-80 (2011)

Pharmacokinetics and metabolic drug interactions
, Current Clinical Pharmacology 1(1): 5-20 (2006)

Pharmacokinetics and metabolic fate of two nitroxides potentially useful as contrast agents for magnetic resonance imaging
, Pharmaceutical Research 1(5): 203-209 (1984)

Pharmacokinetics and metabolism of (R,R)-methoxyfenoterol in rat
, Xenobiotica; the Fate of Foreign Compounds in Biological Systems 40(3): 195-206 (2010)

Pharmacokinetics and metabolism of 14C-brivaracetam, a novel SV2A ligand, in healthy subjects
, Drug Metabolism and Disposition: the Biological Fate of Chemicals 36(1): 36-45 (2008)

Pharmacokinetics and metabolism of 4-O-methylhonokiol in rats
, PhytoTherapy Research 28(4): 568-578 (2014)

Pharmacokinetics and metabolism of BIBF 1120 after oral dosing to healthy male volunteers
, Xenobiotica; the Fate of Foreign Compounds in Biological Systems 41(4): 297-311 (2011)

Pharmacokinetics and metabolism of N-[N-[3-(3-hydroxy-4-methoxyphenyl) propyl]-α-aspartyl]-L-phenylalanine 1-methyl ester, monohydrate (advantame) in the rat, dog, and man
, Food and Chemical Toxicology 49(Suppl. 1): S8-29 (2011)

Pharmacokinetics and metabolism of [14C]anagliptin, a novel dipeptidyl peptidase-4 inhibitor, in humans
, Xenobiotica; the Fate of Foreign Compounds in Biological Systems 43(5): 432-442 (2013)

Pharmacokinetics and metabolism of all-trans- and 13-cis-retinoic acid in pulmonary emphysema patients
, Journal of Clinical Pharmacology 48(1): 96-107 (2008)

Pharmacokinetics and metabolism of dantrolene in horses
, Journal of Veterinary Pharmacology and Therapeutics 34(3): 238-246 (2011)

Pharmacokinetics and metabolism of diltiazem following multiple doses: comparing normotensive rat vs. hypertensive rat models in vivo
, Drug Metabolism Letters 2(2): 146-150 (2008)

Pharmacokinetics and metabolism of eprinomectin in cats when administered in a novel topical combination of fipronil, (S)-methoprene, eprinomectin and praziquantel
, Veterinary Parasitology 202(1-2): 2-9 (2014)

Pharmacokinetics and metabolism of idebenone in healthy male subjects
, European Journal of Clinical Pharmacology 65(5): 493-501 (2009)

Pharmacokinetics and metabolism of midazolam in chimeric mice with humanised livers
, Xenobiotica; the Fate of Foreign Compounds in Biological Systems 42(11): 1128-1137 (2012)

Pharmacokinetics and metabolism of natural methylxanthines in animal and man
, Handbook of Experimental Pharmacology 2011(200): 33-91 (2011)

Pharmacokinetics and metabolism of the dipeptidyl peptidase IV inhibitor carmegliptin in rats, dogs, and monkeys
, Xenobiotica; the Fate of Foreign Compounds in Biological Systems 40(12): 840-852 (2010)

Pharmacokinetics and metabolism of the putative cancer chemopreventive agent cyanidin-3-glucoside in mice
, Cancer ChemoTherapy and Pharmacology 64(6): 1261-1268 (2009)

Pharmacokinetics and metabolism studies on the glucagon-like peptide-1 (GLP-1)-derived metabolite GLP-1(9-36)amide in male Beagle dogs
, Xenobiotica; the Fate of Foreign Compounds in Biological Systems 44(9): 842-848 (2014)

Pharmacokinetics and metabolism update for some recent antipsychotics
, Expert Opinion on Drug Metabolism and Toxicology 7(7): 829-846 (2011)

Pharmacokinetics and metabolite identification of a novel VEGFR-2 and Src dual inhibitor 6-chloro-2-methoxy-N-(2-methoxybenzyl) acridin-9-amine in rats by liquid chromatography tandem mass spectrometry
, Talanta 89: 70-76 (2012)

Pharmacokinetics and metabolite profiling of fimasartan, a novel antihypertensive agent, in rats
, Xenobiotica; the Fate of Foreign Compounds in Biological Systems 44(10): 913-925 (2014)

Pharmacokinetics and milk penetration of difloxacin after a long-acting formulation for subcutaneous administration to lactating goats
, Journal of Dairy Science 93(7): 3056-3064 (2010)

Pharmacokinetics and milk secretion of gabapentin and meloxicam co-administered orally in Holstein-Friesian cows
, Journal of Veterinary Pharmacology and Therapeutics 36(1): 14-20 (2013)

Pharmacokinetics and modeling of immune cell trafficking: quantifying differential influences of target tissues versus lymphocytes in SJL and lipopolysaccharide-treated mice
, Journal of Neuroinflammation 9: 231 (2012)

Pharmacokinetics and nephrotoxicity of amphotericin B-incorporated poly(ethylene glycol)-block-poly(N-hexyl stearate l-aspartamide) micelles
, Journal of Pharmaceutical Sciences 100(6): 2064-2070 (2011)

Pharmacokinetics and ocular disposition of paracetamol and paracetamol glucuronide in rabbits with diabetes mellitus induced by alloxan
, Pharmacological Reports 64(2): 421-427 (2012)

Pharmacokinetics and oral bioavailability of epimedin C after oral administration of epimedin C and Herba Epimedii extract in rats
, Biomedical Chromatography 28(5): 630-636 (2014)

Pharmacokinetics and organ distribution of diarylheptanoid phytoestrogens from Curcuma comosa in rats
, Journal of Natural Medicines 66(3): 468-475 (2012)

Pharmacokinetics and organ distribution of fluorescein in experimental pigs: an input study for confocal laser endomicroscopy of the gastrointestinal tract
, Neuro Endocrinology Letters 31(Suppl. 2): 57-61 (2010)

Pharmacokinetics and ovarian suppression during use of a contraceptive vaginal ring in normal-weight and obese women
, American Journal of Obstetrics and Gynecology 207(1): 39.E1 (2012)

Pharmacokinetics and penetration into synovial fluid of systemical and electroporation administered sinomenine to rabbits
, Biomedical Chromatography 29(6): 883-889 (2015)

Pharmacokinetics and penetration of linezolid into inflamed soft tissue in diabetic foot infections
, European Journal of Clinical Pharmacology 64(11): 1093-1100 (2008)

Pharmacokinetics and penetration of moxifloxacin into infected diabetic foot tissue in a large diabetic patient cohort
, European Journal of Clinical Pharmacology 67(2): 135-142 (2011)

Pharmacokinetics and pharmacodynamic action of budesonide after buccal administration in healthy subjects and patients with oral chronic graft-versus-host disease
, Biology of Blood and Marrow Transplantation 15(3): 336-343 (2009)

Pharmacokinetics and pharmacodynamic biomarkers in early oncology drug development
, European Journal of Cancer 45(Suppl. 1): 436-438 (2009)

Pharmacokinetics and pharmacodynamic changes associated with aging and implications for drug therapy
, Clinics in Geriatric Medicine 28(2): 273-286 (2012)

Pharmacokinetics and pharmacodynamic effects of meloxicam in piglets subjected to a kaolin inflammation model
, Journal of Veterinary Pharmacology and Therapeutics 34(4): 367-375 (2011)

Pharmacokinetics and pharmacodynamic effects of oral GLP-1 and PYY3-36: a proof-of-concept study in healthy subjects
, Clinical Pharmacology and Therapeutics 84(4): 468-474 (2009)

Pharmacokinetics and pharmacodynamic target attainment of intravenous pazufloxacin in the bile of patients undergoing biliary pancreatic surgery
, Journal of ChemoTherapy 26(5): 287-292 (2014)

Pharmacokinetics and pharmacodynamics (PK/PD) of irbesartan in Beagle dogs after oral administration at two dose rates
, Polish Journal of Veterinary Sciences 16(3): 555-561 (2013)

Pharmacokinetics and pharmacodynamics following intravenous administration of recombinant human hepatocyte growth factor in rats with renal injury
, Pharmacology 94(3-4): 190-197 (2014)

Pharmacokinetics and pharmacodynamics in HIV prevention; current status and future directions: a summary of the DAIDS and BMGF sponsored think tank on pharmacokinetics (PK)/pharmacodynamics (PD) in HIV prevention
, Aids Research and Human Retroviruses 29(11): 1418-1427 (2013)

Pharmacokinetics and pharmacodynamics in Japanese and Caucasian subjects after oral administration of dabigatran etexilate
, Thrombosis and Haemostasis 107(2): 260-269 (2012)

Pharmacokinetics and pharmacodynamics in critically ill patients
, Current Opinion in Anaesthesiology 23(4): 472-478 (2010)

Pharmacokinetics and pharmacodynamics in the critically ill child
, Pediatric Clinics of North America 55(3): 735 (2008)

Pharmacokinetics and pharmacodynamics in the development of anti-tuberculosis drugs
, Tuberculosis 88(Suppl. 1): S65 (2008)

Pharmacokinetics and pharmacodynamics in the elderly
, Clinical Advances in Hematology and Oncology 5(3): 181-182 (2007)

Pharmacokinetics and pharmacodynamics in the newborn
, Veterinary Research Communications 32(Suppl. 1): S77 (2008)

Pharmacokinetics and pharmacodynamics of (+)-primaquine and (-)-primaquine enantiomers in rhesus macaques (Macaca mulatta)
, Antimicrobial Agents and ChemoTherapy 58(12): 7283-7291 (2014)

Pharmacokinetics and pharmacodynamics of 3,4-methylenedioxymethamphetamine (MDMA): interindividual differences due to polymorphisms and drug-drug interactions
, Critical Reviews in Toxicology 42(10): 854-876 (2012)

Pharmacokinetics and pharmacodynamics of A77 1726 and leflunomide in domestic cats
, Journal of Veterinary Pharmacology and Therapeutics 35(2): 139-146 (2012)

Pharmacokinetics and pharmacodynamics of ASKP1240, a fully human anti-CD40 antibody, in normal and renal transplanted Cynomolgus monkeys
, Transplantation 97(4): 397-404 (2014)

Pharmacokinetics and pharmacodynamics of AZD6244 (ARRY-142886) in tumor-bearing nude mice
, Cancer ChemoTherapy and Pharmacology 67(2): 349-360 (2011)

Pharmacokinetics and pharmacodynamics of CD4-anchoring bi-functional fusion inhibitor in monkeys
, Pharmaceutical Research 31(3): 809-818 (2014 )

Pharmacokinetics and pharmacodynamics of CHF5074 after short-term administration in healthy subjects
, Alzheimer Disease and Associated Disorders 27(3): 278-286 (2013)

Pharmacokinetics and pharmacodynamics of FSK0808 and Gran after single intravenous drip administration or single subcutaneous administration: comparative study in healthy Japanese adult male subjects
, Drug Development and Industrial Pharmacy 41(3): 470-475 (2015)

Pharmacokinetics and pharmacodynamics of GPI 15715 or fospropofol (Aquavan injection) - a water-soluble propofol prodrug
, Handbook of Experimental Pharmacology 2008(182): 253-266 (2008)

Pharmacokinetics and pharmacodynamics of KR-66223, a novel DPP-4 inhibitor
, Drug Metabolism and Pharmacokinetics 27(2): 216-222 (2012)

Pharmacokinetics and pharmacodynamics of LC15-0444, a novel dipeptidyl peptidase IV inhibitor, after multiple dosing in healthy volunteers
, British Journal of Clinical Pharmacology 68(6): 883-890 (2009)

Pharmacokinetics and pharmacodynamics of LCZ696, a novel dual-acting angiotensin receptor-neprilysin inhibitor (ARNi)
, Journal of Clinical Pharmacology 50(4): 401-414 (2010)

Pharmacokinetics and pharmacodynamics of LGD-3303 [9-chloro-2-ethyl-1-methyl-3-(2,2,2-trifluoroethyl)-3H-pyrrolo-[3,2-f]quinolin-7(6H)-one], an orally available nonsteroidal-selective androgen receptor modulator
, Journal of Pharmacology and Experimental Therapeutics 328(2): 663-670 (2009)

Pharmacokinetics and pharmacodynamics of MK-5046, a bombesin receptor subtype-3 (BRS-3) agonist, in healthy patients
, Journal of Clinical Pharmacology 52(9): 1306-1316 (2012)

Pharmacokinetics and pharmacodynamics of Phor21-betaCG(ala), a lytic peptide conjugate
, Journal of Pharmacy and Pharmacology 60(11): 1441-1448 (2008)

Pharmacokinetics and pharmacodynamics of TBR-652, a novel CCR5 antagonist, in HIV-1-infected, antiretroviral treatment-experienced, CCR5 antagonist-naïve patients
, Antimicrobial Agents and ChemoTherapy 55(6): 2768-2774 (2011)

Pharmacokinetics and pharmacodynamics of TMC207 and its N-desmethyl metabolite in a murine model of tuberculosis
, Antimicrobial Agents and ChemoTherapy 56(3): 1444-1451 (2012)

Pharmacokinetics and pharmacodynamics of a bolus and infusion of cangrelor: a direct, parenteral P2Y12 receptor antagonist
, Journal of Clinical Pharmacology 50(1): 27-35 (2010)

Pharmacokinetics and pharmacodynamics of a chimeric/humanized anti-CD3 monoclonal antibody, otelixizumab (TRX4), in subjects with psoriasis and with type 1 diabetes mellitus
, Journal of Clinical Pharmacology 50(5): 494-506 (2010)

Pharmacokinetics and pharmacodynamics of a constant rate infusion of fentanyl (5 μg/kg/h) in awake cats
, American Journal of Veterinary Research 75(8): 716-721 (2014)

Pharmacokinetics and pharmacodynamics of a known active PPI with a novel Dual Delayed Release technology, dexlansoprazole MR: a combined analysis of randomized controlled clinical trials
, Current Medical Research and Opinion 25(3): 627-638 (2010)

Pharmacokinetics and pharmacodynamics of a new ACT formulation: Artesunate/Amodiaquine (TRIMALACT) following oral administration in African malaria patients
, European Journal of Drug Metabolism and Pharmacokinetics 34(3-4): 133-142 (2009)

Pharmacokinetics and pharmacodynamics of a new highly secured fibrinogen concentrate
, Journal of Thrombosis and Haemostasis 6(9): 1494-1499 (2008)

Pharmacokinetics and pharmacodynamics of a new reformulated microemulsion and the long-chain triglyceride emulsion of propofol in beagle dogs
, British Journal of Pharmacology 158(8): 1982-1995 (2009 )

Pharmacokinetics and pharmacodynamics of a novel triazole, isavuconazole: mathematical modeling, importance of tissue concentrations, and impact of immune status on antifungal effect
, Antimicrobial Agents and ChemoTherapy 53(8): 3453-3461 (2009)

Pharmacokinetics and pharmacodynamics of a polyethylene glycol (PEG)-conjugated GLP-receptor agonist once weekly in Chinese patients with type 2 diabetes
, Journal of Clinical Pharmacology 55(2): 152-158 (2015)

Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant
, Investigative Ophthalmology and Visual Science 52(1): 80-86 (2011)

Pharmacokinetics and pharmacodynamics of acetylsalicylic acid after intravenous and oral administration to healthy volunteers
, Clinical Pharmacology 6: 51-59 (2014)

Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients
, Clinical Microbiology Reviews 27(4): 753-782 (2014)

Pharmacokinetics and pharmacodynamics of aliskiren, an oral direct renin inhibitor
, Pharmacological Reports 60(5): 623-631 (2008)

Pharmacokinetics and pharmacodynamics of amphotericin B deoxycholate, liposomal amphotericin B, and amphotericin B lipid complex in an in vitro model of invasive pulmonary aspergillosis
, Antimicrobial Agents and ChemoTherapy 54(8): 3432-3441 (2010)

Pharmacokinetics and pharmacodynamics of anastrozole in pubertal boys with recent-onset gynecomastia
, Journal of Clinical Endocrinology and Metabolism 94(8): 2975-2978 (2009)

Pharmacokinetics and pharmacodynamics of antibacterial agents
, Infectious Disease Clinics of North America 23(4): 791 (2009)

Pharmacokinetics and pharmacodynamics of antibacterial agents: on account of febrile neutropenic patients
, Revista Chilena de Infectologia 28(6): 537-545 (2011)

Clinical Study of 2014 ISUP New Grade Group Classification for Prostate Cancer Patients Treated by Androgen Deprivation Therapy
, Hinyokika Kiyo. Acta Urologica Japonica 64(1): 7-11 (2018)

Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants
, Clinical Pharmacokinetics 53(7): 581-610 (2014)

Pharmacokinetics and pharmacodynamics of antibiotic therapy
, Der Anaesthesist 63(10): 775-782 (2014)

Pharmacokinetics and pharmacodynamics of antibiotics in biofilm infections of Pseudomonas aeruginosa in vitro and in vivo
, Methods in Molecular Biology 1147: 239-254 (2014)

Pharmacokinetics and pharmacodynamics of antifungal drugs in children
, Archives de Pediatrie 18(Suppl. 1): S42 (2011)

Pharmacokinetics and pharmacodynamics of antifungals in children and their clinical implications
, Clinical Pharmacokinetics 53(5): 429-454 (2014)

Pharmacokinetics and pharmacodynamics of antifungals in children: clinical implications
, Drugs 74(8): 891-909 (2014)

Pharmacokinetics and pharmacodynamics of antimicrobial drugs
, Expert Opinion on Drug Metabolism and Toxicology 5(5): 475-487 (2009)

Pharmacokinetics and pharmacodynamics of antimicrobial drugs in intensive care unit patients
, Shock 39(Suppl. 1): 24-28 (2013)

Pharmacokinetics and pharmacodynamics of antimicrobial therapy used in child osteoarticular infections
, Archives de Pediatrie 14(Suppl. 2): S122 (2007)

Pharmacokinetics and pharmacodynamics of antiretrovirals in the central nervous system
, Clinical Pharmacokinetics 53(10): 891-906 (2014)

Pharmacokinetics and pharmacodynamics of artesunate and dihydroartemisinin following oral treatment in pregnant women with asymptomatic Plasmodium falciparum infections in Kinshasa DRC
, Malaria Journal 10: 49 (2011)

Pharmacokinetics and pharmacodynamics of basal insulins
, Diabetes Technology and Therapeutics 13(Suppl. 1): S15 (2011)

Pharmacokinetics and pharmacodynamics of basiliximab in Japanese pediatric renal transplant patients
, International Journal of Clinical Pharmacology and Therapeutics 48(3): 214-223 (2010)

Pharmacokinetics and pharmacodynamics of biapenem in critically ill patients under continuous venovenous hemodiafiltration
, Japanese Journal of Antibiotics 61(5): 303-313 (2008)

Pharmacokinetics and pharmacodynamics of boosted once-daily darunavir
, Journal of Antimicrobial ChemoTherapy 69(10): 2591-2605 (2014)

Pharmacokinetics and pharmacodynamics of broccoli sprouts on the suppression of prostate cancer in transgenic adenocarcinoma of mouse prostate (TRAMP) mice: implication of induction of Nrf2, HO-1 and apoptosis and the suppression of Akt-dependent kinase pathway
, Pharmaceutical Research 26(10): 2324-2331 (2009)

Pharmacokinetics and pharmacodynamics of butorphanol following intravenous administration to the horse
, Journal of Veterinary Pharmacology and Therapeutics 36(1): 21-30 (2013)

Pharmacokinetics and pharmacodynamics of calcium-vitamin D(3) chewable tablets: a single-blind, multiple-dose study in postmenopausal women
, Expert Opinion on Drug Metabolism and Toxicology 7(7): 785-791 (2011)

Pharmacokinetics and pharmacodynamics of ceftaroline
, Enfermedades Infecciosas y Microbiologia Clinica 32(Suppl. 2): 15-20 (2014)

Pharmacokinetics and pharmacodynamics of chlorambucil delivered in long-circulating nanoemulsion
, Journal of Drug Targeting 18(2): 125-133 (2010)

Pharmacokinetics and pharmacodynamics of chlorambucil delivered in parenteral emulsion
, International Journal of Pharmaceutics 360(1-2): 115-121 (2008)

Pharmacokinetics and pharmacodynamics of cinacalcet in hepatic impairment : phase I, open-label, parallel-group, single-dose, single-centre study
, Clinical Drug Investigation 28(10): 635-643 (2008)

Pharmacokinetics and pharmacodynamics of cinacalcet in patients with hyperparathyroidism after renal transplantation
, American Journal of Transplantation 8(4): 803-810 (2008)

Pharmacokinetics and pharmacodynamics of ciprofloxacin in critically ill patients after the first intravenous administration of 400 mg
, Advances in Medical Sciences 57(2): 217-223 (2012)

Pharmacokinetics and pharmacodynamics of combined use of lopinavir/ritonavir and rosuvastatin in HIV-infected patients
, Antiviral Therapy 12(7): 1127-1132 (2007)

Pharmacokinetics and pharmacodynamics of controlled release insulin loaded PLGA microcapsules using dry powder inhaler in diabetic rats
, Biopharmaceutics and Drug Disposition 31(2-3): 189-201 (2010)

Pharmacokinetics and pharmacodynamics of curcumin
, Advances in Experimental Medicine and Biology 595: 453-470 (2007)

Pharmacokinetics and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor, are not affected by moderate hepatic impairment
, Journal of Clinical Pharmacology 48(12): 1411-1419 (2008)

Pharmacokinetics and pharmacodynamics of danaparoid during continuous venovenous hemofiltration: a pilot study
, Critical Care 11(5): R102 (2007)

Pharmacokinetics and pharmacodynamics of dapagliflozin, a novel selective inhibitor of sodium-glucose co-transporter type 2, in Japanese subjects without and with type 2 diabetes mellitus
, Diabetes Obesity and Metabolism 13(4): 357-365 (2011)

Pharmacokinetics and pharmacodynamics of dermorphin in the horse
, Journal of Veterinary Pharmacology and Therapeutics 38(4): 321-329 (2015)

Pharmacokinetics and pharmacodynamics of detomidine following sublingual administration to horses
, American Journal of Veterinary Research 72(10): 1378-1385 (2011)

Pharmacokinetics and pharmacodynamics of dexamethasone after oral administration in apparently healthy horses
, American Journal of Veterinary Research 71(7): 831-839 (2010)

Pharmacokinetics and pharmacodynamics of diclofenac in the presence and absence of glibenclamide in the rat
, Journal of Pharmacy and Pharmaceutical Sciences 11(3): 68-76 (2008)

Pharmacokinetics and pharmacodynamics of different modes of insulin pump delivery. A randomized, controlled study comparing subcutaneous and intravenous administration of insulin aspart
, Diabetic Medicine 28(2): 230-236 (2011)